Review of the Evidence on the Use of Arbitration or Consensus within Breast Screening; A Systematic Scoping Review by Hackney, Lisa
 Coventry University
MASTER OF SCIENCE BY RESEARCH
Review of the Evidence on the Use of Arbitration or Consensus within Breast








Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of this thesis for personal non-commercial research or study
            • This thesis cannot be reproduced or quoted extensively from without first obtaining permission from the copyright holder(s)
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.




Master of Science by Research in 
Clinical Practice: Review of the 
Evidence on the Use of Arbitration or 
Consensus within Breast Screening; A 
Systematic Scoping Review. 
 





A thesis submitted in partial fulfilment of the University’s 







Breast screening involves the interpretation and reporting of mammographic images.  
In the UK, the images are independently double reported, and inherent with this 
strategy is that readers may disagree with their decision as to whether a potential 
abnormality requires further investigation.  Discrepant findings require resolution, 
which is currently achieved by some form of arbitration or consensus.  
The primary focus of this scoping review was to establish what evidence is there to 
inform arbitration and consensus processes and what is their effectiveness within 
mammography reporting.   A systematic scoping review was undertaken to identify 
the ‘nature and extent of research evidence’.   
The first stage of the process describes the various sources of information that were 
searched (databases, conference proceedings, personal contacts and unpublished 
data sources) using varying search strategies.  A 3-stage process was utilised to 
screen a large volume of literature (601) against the inclusion and exclusion criteria.  
26 papers were retained for the final review.   
The results of the data extraction were synthesized into key features and emerging 
themes, with generalizability discussed relative to UK practice. The review has 
identified a lack of guidance and underpinning evidence to inform how best to use 
arbitration or consensus to resolve discordant reads.  The strengths and weaknesses 
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Arbitration The use of a third reader to decide on case management when there is 
disagreement between the initial reporters. 
Blinded reading The 2nd reader is unaware of the 1st readers report 
Consensus A group of film readers who decide on case management when there is 
disagreement between the initial reporters 
Craniocaudal view A standard screening projection of the breast. The x-ray beam 
enters at the cranial aspect of the breast and exits at the caudal aspect. 
Double-reporting A breast screening protocol in which two film readers report the 
same images independently. 
False negative A cancer erroneously discharged at screen reporting or assessment. 
False positive A normal case incorrectly recalled for assessment. 
Full-field digital mammography The direct acquisition of a digital X-ray image of the 
breast. 
Incident screen A follow-up screening mammogram after a predetermined interval 
Interval cancer A cancer that presents clinically between screening rounds. 
Medio-lateral oblique view A standard screening projection of the breast taken at 
an oblique angle 
Prevalent screen The first screening mammogram 
Reader An individual trained to report breast-screening mammograms 
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RSS Rich Site Summary 
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Symposium  
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Chapter 1. Introduction 
This thesis is set in the context of breast screening, which involves the interpretation 
and reporting of mammographic images.  In the UK, the images are independently 
double reported, and inherent with this strategy is that readers may disagree with 
their decision as to whether a potential abnormality requires further investigation.  
Discrepant findings require resolution, which is currently achieved by some form of 
arbitration or consensus.  The primary focus of this scoping review is to establish 
what evidence is there to inform arbitration and consensus processes and their 
effectiveness within mammography reporting.  
1.1 Breast Screening Context 
1.1.1 Breast Cancer Incidence Worldwide 
An estimated 1.6 million women were diagnosed with breast cancer worldwide in 
2012, representing the most common cancer in developed and developing countries 
(Ferlay et al. 2013). The strongest risk factor for female breast cancer is age, and with 
population ageing, it is therefore predicted that this rate will continue to rise.   
1.1.2 Breast Cancer Costs in the UK 
As with any healthcare provision, there is the consideration of the costs of screening, 
diagnosis and treatment.  The National Cancer Information Centre (NCIN 2012) 
report that breast cancer costs in the UK amount to an excess of £5.7 billion annually 
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(NCIN 2012) with £441.0M projected inpatient costs for 2016 (Local Cancer 
Intelligence 2016). 
1.1.3 UK Breast Cancer Incidence 
The most recent data (2013) for which statistics are publically available in the UK, 
demonstrate that ‘breast cancer is the most frequent female cancer’ (Figure 1), with 
‘1 in 8 women developing the disease in their lifetime’ and nearly ‘12,000 subsequent 
related deaths’ annually (Office for National Statistics 2015). Cancer Registration 
statistics (2013) validates that 43.5% of UK female breast cancer cases are diagnosed 
in the 50-59-age range and 34.3% in the 60-69-age range, with a 6% increase in 
incidence rates in UK females between 2002-2004 and 2011-2013. 
 
Figure 1  Most Common Cancers in Females, UK, 2013.  Cancer Research UK,  
http://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/common-cancers-
compared#heading-Two, Accessed February 2016. 
This item has been removed due to 3rd Party Copyright. The 




The combination of breast cancer prevalence and demographic trends contributed 
to the founding of the UK National Health Service (NHS) Breast Screening 
Programme (NHSBSP), which was inaugurated in 1988 (Forrest 1986) to facilitate 
early detection of the disease. The fundamental purpose of the NHS is to improve 
health and well-being (Department of Health 2008) and although the incidence of 
breast cancer has continued to rise in the UK over the last decade (Figure 2) the 
mortality rates from the disease have fallen.  
 
Figure 2   Percentage Change in Female Mortality Rates.  Cancer Research UK,  
www.cancerresearchuk.org/sites/default/files/cstream-node/cs_mort_20common_females.pdf, 
Accessed February 2016. 
This item has been removed due to 3rd Party Copyright. The unabridged 




In recent years, some controversy has emerged over the continued overall benefit of 
breast screening.  This led to the commissioning of an independent investigation to 
evaluate the evidence on ‘benefits and harms of breast screening’ from a UK 
perspective (Marmot et al. 2013: 226).  Autier et al. (2010:4411) report that a 35% 
reduction in breast cancer mortality in England and Wales (period 1989 -2006) can 
be credited to ‘improved treatments (surgical, radiotherapy/chemotherapy regimes 
and hormonal therapies) and improved delivery of specialist care by multi-
disciplinary teams’.   
Overall the Marmot report concluded that screening does ‘prevent around 1,300 
breast cancer deaths in the UK per year’ (Marmot et al. 2013: 226).  However, 
approximately ‘4,000 women each year aged 50 to 70 in the UK’ will undergo 
‘treatment for a condition that would never have caused them harm’ (Marmot et al. 
2013: 226). With this information in mind, it is imperative that screening 
programmes maximise cancer detection while minimising excessive false-positive 
recalls and recalls for non-life threatening disease.  
1.2 Breast Screen Reporting 
Whilst double reporting is the norm in many European countries, the professionals 
undertaking the task differ in that the UK is unique in utilising non-medical 
practitioners; radiographers trained to specialise in breast imaging reporting.   
Double reporting requires that two individuals independently read the mammogram 
and make a final conclusion (report) on case management.  If there is disagreement 
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between the two reporters there needs to be a resolution on whether to recall for 
further investigation, or conclude the case is normal and discharge to routine three 
yearly screening.  When a discrepant case is identified, the two reporters may 
attempt to reach agreement through discussion (consensus), or send to a panel of 
reporters for evaluation (consensus).  Alternatively, an independent third person 
may review the case and make the final decision (arbitration). 
Upon implementation of the NHSBSP in 1988, Consultant Radiologists or other 
medically qualified individuals were the only ones considered to have the necessary 
skill set to read and interpret mammographic images. However, severe radiologist 
shortages necessitated a change in service delivery.  Literature began to emerge that 
Radiographer interpretation of mammograms was as accurate as that of Radiologists 
(Pauli et al., 1996).  The NHS Plan (DH 2000) was pivotal in developing advanced 
radiographic practice, and radiographer reporting of screening mammography 
formed part of this strategy (DH 2007a).  
In 2011, the DOH recognised that radiographer reporting was crucial to attain health 
service improvements whilst maximising patient care (DH 2011). 
1.3 Changing UK Context  
Guidance on arbitration personnel within the UK NHSBSP is currently under review 
by an expert group.  It is recognised that, to maintain the current quality standards 
and avoid delays in patient management, the extension of arbitration duties to non-
medics may now need to be considered (Bennett et al. 2012).  Concerns about the 
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future availability of specialist radiologists have been highlighted in a recent Royal 
College of Radiologists (RCR 2016) publication.  This predicts the retirement of 21% 
of breast radiologists in the next five years, together with a potential 2.2 million 
increase in women eligible for screening if the age extension is implemented (based 
on current population figures).  Changing UK practice reflects a shift in focus away 
from job titles to quality standards for tasks and responsibilities (NHSBSP 2011).  It is, 
therefore, an opportune time to establish what evidence there is to support 
different models of arbitration or consensus review in breast screening.  
1.4 Thesis Aims and Objectives  
1.4.1 Aim 
The aim of this thesis is to review and evaluate the evidence to support the 
effectiveness of different strategies utilised to resolve discordance in breast 
screening reports.  For the purpose of this thesis effectiveness is defined in terms of 
recall rates, cancer detection rate, Positive Predictive Value (PPV) and programme 
sensitivity/specificity.  Although cost-effectiveness is an essential component of 
service delivery, it is not considered in this thesis. 
1.4.2 Objectives 
The main objectives of this research are:  
 
Objective 1: To identify the ‘nature and extent of research evidence’ (Booth, 
Papaioannou and Sutton 2012: 27) that has been undertaken on arbitration and 
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consensus processes within mammography reporting. 
 
Objective 2: To synthesise the known evidence for the effectiveness of the processes 
used to resolve discordant reports and to identity gaps in the evidence base to 
inform further research if required. 
1.5 Chapter 1 Summary 
This chapter has identified the prevalence and trends of breast cancer and the 
rationale for the founding of the UK NHSBSP. Controversies of the continued overall 
benefit of breast screening were discussed. The concept of double reading was 
introduced and that the UK implemented radiographer reporting to sustain this. 
Double reading inherently results in discordant cases, which require resolution. The 
next chapter details the NHSBSP processes, reporting strategies and methods to 
resolve discordant reports.  
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Chapter 2.  Background 
The following section describes the complexities of the UK NHSBSP, with differences 
relevant to other countries highlighted. After clarifying the NHSBSP process, 
assessment, key standards, and mammography as a screening examination, the 
chapter introduces the different strategies utilised for reporting.   
2.1 UK National Health Service Breast Screening Programme (NHSBSP) 
Breast screening primarily entails the mammographic imaging of asymptomatic 
woman.  At inception, the UK programme invited all women (age 50 - 64) registered 
with a GP for screening on a three yearly basis.  Over time, the programme has 
evolved and expanded to now incorporate two-view (Medio-lateral oblique and 
Cranio-caudal) digital mammography automatically to women aged 50-70, with the 
option for the over 70 to self-refer. In England, a randomised controlled trial is 
presently underway to establish if there is a benefit in extending the age range 








Figure 3 Flowchart demonstrating the screening process (adapted from DOH 2013). 
 
Figure 3 provides an explanatory diagrammatic flow chart of the screening process.  
In the screening programme mammograms are deemed normal (which includes 
benign findings), or abnormal if there are indeterminate or suspicious findings with 
This item has been removed due to 3rd Party Copyright. The unabridged 




the latter resulting in a recall for further assessment.  Clinical recall may also be 
instigated in women whose mammograms are considered normal but for whom 
there is documentation at the screening of relevant signs or symptoms of breast 
cancer.  
2.2 NHSBSP Assessment Process/Triple Assessment 
The aim of the assessment stage in Figure 3 is to obtain a ‘definitive and timely 
diagnosis’ (NHSBSP 2010:1) of potential abnormalities. During the assessment, the 
workup of cases can involve many options. Ranging from ultrasound only with or 
without a clinical breast examination (CBE), other cases will require further 
mammographic views, and ultrasound (U/S) +/- CBE; and in some cases complete 
triple assessment is undertaken (additional imaging, histological sampling and CBE). 
This modified triple approach incorporating U/S and Needle Core Biopsy (NCB) 
(rather than Fine Needle Aspiration Cytology (FNAC)) is evidenced to achieve an 
accurate diagnosis in 99% of cases (Wai et al. 2013). The individual who is leading 
the assessment clinic (Consultant Radiologist or Consultant Radiographer as per 
NHSBSP 2010) makes the decision on which, or if all components of the triple 
assessment process are required.  Subsequently, the decision to discharge a lady 
back to routine screening also lies with this individual, although it is recommended 
good practice to obtain a 2nd opinion.   
A multi-disciplinary team (MDT) involved in the patient management includes core 
members consisting of a consultant radiologist and/or consultant radiographer; 
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breast surgeon; pathologist; oncologist and a clinical nurse specialist in breast care.   
The MDT meeting offers a forum to discuss individual cases and a collaborative 
decision is made regarding an appropriate programme of treatment specific to 
individual patient needs. 
2.3 UK Key National Standards  
To achieve high quality and consistent outcomes, a number of key standards have 
been set by the National Coordination Team as a means of monitoring the 
performance of the NHSBSP.  Appendix A lists the current National Minimum 
Standards for the NHSBSP, which are designed to allow for high detection 
(sensitivity) of breast cancers while limiting unnecessary recalls and biopsies for 
benign findings.  These quality standards were also introduced to create a 
sustainable programme with respect to cost, time and workforce implications.  
Particularly important for this research are selected Standards 2,3,7, 10 and 13 (see 
Table 1) as they relate to maximising the number of cancers detected (standard 2), 
and picking up the cancers at an early stage (standard 3).  Standard 7 is especially 
important as the process of arbitration or consensus of discrepant reads is a 
contributory factor in ensuring that an excess of false positive cases are not recalled.  
However, this process needs to be performed in a timely manner to ensure that 
normal results are received within two weeks of attendance for the screening 
mammogram and a recall to an assessment clinic occurs within three weeks 
(standard 13).  Decision making on discrepant cases is particularly challenging as 
small cancers are often subtle and display minimal mammographic changes.   
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Table 1 Selected Current National Minimum Standards for the NHSBSP 
Objective  Criteria Minimum standard Achievable 
standard 
2. To maximise the 
number of cancers 
detected 
 
a) The rate of invasive 
cancers detected in eligible 
women invited and 
screened  
Prevalent screen >3.6 per 
1,000  
Incident screen >4.1 per 
1,000  
Prevalent screen 
>5.1 per 1,000  
Incident screen 
>5.7 per 1,000 
b) The rate of cancers 
detected that are in situ 
carcinoma 
Prevalent screen >0.5 per 
1,000  
>1.4 
c) Standardised detection 
ratio (SDR) 
Incident screen >0.6 per 
1,000 
 > 1.0 
 
3. To maximise the 




The rate of invasive cancers 
less than 15 mm in diameter 
detected in eligible women 
invited and screened 
 
Prevalent screen >2.0 per 
1,000 
Incident screen > 2.3 per 
1,000 
Prevalent screen 
>2.8 per 1,000  
Incident screen 
>3.1 per 1,000 
7. To minimise the 
number of women 
screened who are 
referred for further 
tests 
a) The percentage of 
women who are referred for 
assessment  
b) The percentage of 
women screened who are 
placed on short term recall 
Prevalent screen <10% 







10. To minimise the 
number of cancers 
presenting between 
screening episodes 
in the women 
screened 
The rate of cancers 
presenting in screened 
women  
a) in the two years following 
a normal screening episode 
b) in the third year following 
a normal screening episode 
Expected standard 1.2 per 1,000 women 
screened in the first two years 1.4 per 1,000 
women screened in the third year 
 
13. To minimise the 




The percentage of women 
who attend an assessment 
centre within three weeks of 





Therefore, to minimise a cancer presenting between the three yearly screening 
episodes it is imperative that these cases are rigorously evaluated to prevent a 
cancer case being incorrectly discharged back to routine screening (standard 10). 
2.4 Recall Rate 
 UK guidelines define minimum (<10% Prevalent screen and <7% Incident screen) 
and achievable standards (<7% prevalent screen and <5% incident screen) for recall 
rates (objective 7 Table 1).  However, there is variance in these standards 
internationally (Smith-Bindman et al. 2003).  European guidelines advise a recall rate 
of less than 5% for prevalent screens and less than 3% for subsequent screens (Perry 
et al. 2008).  The Dutch Screening Programme is reported to have the lowest recall 
rates worldwide averaging 1.6%.  A low recall rate is not necessarily beneficial 
because this may be at the expense of a lower sensitivity. Recall rates are also not 
directly comparable internationally because of differences in the recommended 






Table 2 Demonstrates the international institutional variance in recommended screening age and 
interval 
2.5 Mammography Accuracy and Interpretation of Images 
It is well documented that mammography is not a perfect screening test (Birdwell 
2009) with accuracy being a combination of both sensitivity and specificity.  
Sensitivity is a measure of the true positives (the proportion of cancer cases correctly 
Institution  Screening Interval High-risk 
Society Country 40-49 Interval 50-
70 









Y 1-2 Y 1-2 Y 1 
American College 
of Radiology 
USA Y 1 Y 1 Y 1 Y 1 
National Cancer 
Institute 




































France N - Y 2 Y-
74 




UK N - Y  3 Y 3 Y 1 
Swedish National 
Board of Health 
and Welfare 









recalled) and specificity a measure of the true negatives (the proportion of normal 
cases correctly returned to routine screening). A meta-analysis of 9 studies 
undertaken by Mushlin et al. (1998) estimated a breast screening sensitivity of 
between 83% and 95%, with a wide range of individual study results (39% to >90%). 
However, it needs to be acknowledged that this review relates to the pre-digital era. 
The more recent UK Tommy trial (2015) reported digital mammography sensitivity as 
87% but with a specificity of only 58%. 
2.6 Reader Performance 
A number of confounding factors may also impact on mammographic detection of 
tumours; some breast cancers are mammographically occult (not visible on 
mammography), and certain tumour types are notoriously difficult to perceive as 
they may only exhibit minimal mammographic changes or portray features that 
overlap with benign and normal variants. A further limitation of conventional 2-
Dimensional (2D) mammography is overlapping normal or dense breast tissue, which 
may obscure underlying lesions (Laming and Warren 2000).  
Although there have been technological advances in the equipment (film to digital 
transition) and techniques, (Computer Aided Detection (CAD), tomosynthesis 3-
Dimensional (3D) imaging, and contrast enhanced mammography) the interpretation 
of the images is still crucially dependent on individual human decision-making skills. 
Numerous studies have reported the considerable inter-observer variability that 
exists within mammography reporting, (Berg et al. 2000, Berg et al. 2002, Duijm et 
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al. 2009 and Skaane et al. 2008) with inconsistent evidence on whether improved 
reader performance correlates to experience and reading volumes (Theberge et al. 
2014, Buist 2011, Barlow 2004 and Miglioretti 2009). False-negative interpretations 
are a consequence of either perception errors or interpretative errors (Cornford et al. 
2005) with fatigue a possible contributory factor (Taylor-Philips et al. 2011). The 
principal complexity for reporters is balancing the trade-off relationship of attaining 
a high sensitivity whilst minimising false positives (Wolf et al. 2015), which impact 
adversely on patient wellbeing (Bond et al. 2015) and represent cost implications in 
time and resources.   
2.7 Reporting of Screening Mammograms 
Different reporting strategies are utilised in various regions of the world.  In the 
United States, single radiologist reporting or single radiologist reporting with CAD 
are commonly employed.  Although CAD systems are designed to aid reader 
perception, this technology remains a topic of continuing research.  A recent 
retrospective review by Lehman et al. (2015:1837) reports that CAD ‘does not 
improve diagnostic accuracy’ and concludes ‘insurers pay more for CAD with no 
established benefit for women’. 
A meta-analysis by Taylor and Potts (2008) concluded that double reading could 
increase cancer detection rates by 10% compared to single reading at the 
expenditure of relatively small increases in recall rates. Double reporting by 
Radiologists specialised in breast screening is the European standard (Perry et al. 
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2008).  Unique to the UK is double reporting undertaken by non-medics (trained 
radiographers).  This was validated in 2012 following an extensive NHSBSP research 
project (Non-Discordant Radiographer Only Reporting - NDROR) (Bennett et al. 2012).  
The success of this system has since led researchers in other countries to investigate 
radiographer interpretation of mammograms (Debono et al. 2015, Torres-Mejia et al. 
2015 and Moran and Warren-Forward 2016). 
A variation also exists with regards to how double reporting is undertaken.  This may 
be in a blinded /independent manner (the 2nd reader is not aware of the 1st 
reader’s decision) or non-blinded (the 2nd reader is aware of the 1st reader’s 
decision). In a recent review, Klompenhouwer et al. (2016a) has identified that there 
are only a limited number of studies that have compared the advantages and 
disadvantages of these reporting strategies, and that arbitration reduces programme 
sensitivity when blinded double reading is performed.  In the UK it is questionable as 
to whether true blinding occurs in practice; from clinical experience, only one set of 
assessment paperwork is produced and therefore the 2nd reader is aware when 
there is discordance and potentially could change their opinion after reviewing the 
case. 
Following the double reading, if there is a concordant negative result (both readers 
agree that the woman should not be referred) routine screening is instigated in 3-
years’ time (Figure 4).  If there is a concordant positive result (both readers agree 
that the woman should be referred) recall to assessment is automatically initiated in 
some centres.  Inherent with double reporting is the probability that the two readers 
29 
 
will differ on their opinion regarding recall (Figure 4).  Unilateral recall, i.e. women 
are recalled if either one of the readers recommended further assessment, is 
associated with high recall rates and therefore discrepant double readings are 
mainly resolved by some form of arbitration or consensus strategy. 
 
 
Figure 4 Flow chart demonstrating a normal and an arbitration-reporting scenario in UK practice.   
The abnormal read by the second reporter instigates the arbitration or consensus 
process.  The final outcome from the processes is either abnormal and recall to 
assessment or normal and return to routine screening. 
2.8 Resolving Discordant Readings 
When there is discordance between the two readers the most common decision 
methods utilised are arbitration by a third independent reader or some form of 
consensus review.  The independent third reader or lead of the consensus review 
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currently must be a medic as stipulated by NHSBSP guidance.  
 Consensus review can involve many differing approaches.  Firstly, the initial two 
readers may attempt to reach an agreement. Secondly, the consensus discussion 
may include the two original reporters and additional film-reading members within 
the team.  An alternative is consensus review by film readers not including the initial 
reporters.  Finally, complex pathways also exist where both consensus and 
arbitration are undertaken in the decision-making process.  
Kerr and Tindale (2004) and Bankier et al. (2010) describe the complexities of 
dynamics that exist within consensus discussions where one reader is the dominant 
and opinions are not equally weighted.  The performance-reducing effects of ‘group 
think’ (Bankier et al. 2010: 14) are also an important consideration in consensus 
where it is evidenced that individuals may change their judgment to what they 
‘believe others want to hear’ (Bankier et al. 2010: 16). 
 
2.9 Chapter 2 Summary 
This chapter has described the reporting processes and standards within breast 
screening. It has highlighted that there are varying methods for resolving discordant 
double reporting.  Finally, the chapter discussed that while there is national 
momentum for delegation of arbitration to radiographers, little is currently known 
about the effectiveness of arbitration versus consensus and whether one strategy 
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produces improved performance in a breast-screening unit.  No systematic reviews 
to date have been undertaken on arbitration or consensus within mammography 
reporting and therefore a scoping review is required to establish the nature and 
volume of evidence to inform the processes and their effectiveness.  The next 





Chapter 3. Methodology 
The preceding chapters have established the absence of a systematic review of 
arbitration and consensus processes used in mammography for resolution of 
discordant reports.  Different forms of evidence review can be undertaken, 
depending on the type of research available. A Cochrane systematic review is 
considered to be one of the most dependable forms of evidence (Cates, Stovold and 
Welsh 2014) due to its transparency, objectivity and ability to minimize bias.  
However, Cochrane reviews are usually tightly focused on quantitative data with 
confined inclusion parameters.  Where the evidence reviewed is qualitative, a 
narrative review might be selected.  This type of review will aim to identify key 
literature from database searching and may consider grey literature and on-going 
research but will not extend to ‘reference list checking, hand searching journals or 
contact with experts’ (Booth, Papaioannou and Sutton 2012:83). In the present study 
it was considered that a scoping review would provide the best overview of the 
current landscape.  A scoping review is described as a method that exceeds a 
traditional narrative review and can be particularly relevant in generating new 
insights, gaps within the evidence and can aid to inform future scope and costs of a 
systematic review (Armstrong et al. 2011). By demonstrating to what extent 
arbitration and consensus has been investigated, and possibly discovering under-
studied areas as well as established sub-fields, recommendations can be made based 




This chapter will describe the systematic method used for identifying the literature 
(searching and screening), and the implications of using varying sources.  Data 
extraction, critique of quality assessment of included studies, and the methodology 
for synthesis of the study findings are also presented and discussed (Hemingway and 
Brereton 2009).  
3.1 Search Strategy 
A broad-based research review (Labin et al. 2012) is a structured method governed 
by systematic decision rules. Kable et al. (2012) describe a 12-step approach for 
documenting an effective search strategy, which was considered plausible for this 
study.  
1. PURPOSE STATEMENT. 
The aim was to review literature pertinent to mammography arbitration or 
consensus. The primary step was defining the scope of the question, which was 
challenging and required refinement and development over a period of time.  The 
PICO parameters below were utilised in order to ensure a clearly articulated scope of 
enquiry (Armstrong et al. 2011). This was considered a significant part of the scoping 
review process as it influenced the succeeding stages and ultimately the final 
outcome. 
P - Healthcare Professionals: 
I – Arbitration/consensus: 
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C – No arbitration or consensus/highest reader recall: 
O – Cancer detection/sensitivity/specificity/PPV: 
The PICO framework was not limited to breast screening.  Following discussion, it 
was identified that it would be relevant to assess if there was any evidence relating 
to arbitration within a symptomatic cancer setting that could be transferable.  
Particular emphasis was placed on studies evaluating the impact of 3rd reader 
arbitration or consensus processes incorporating differing reporting strategies 
(blinded, non-blinded).  Various sources of information were searched (databases, 
conference proceedings, and unpublished data sources) using varying search 
strategies (combinations of keywords and subject headings) in an effort to exhaust 
all sources.  The aim of the scoping review was to ascertain primary and secondary 
outcomes of:  
Primary Outcome 
 What evidence is there to inform arbitration processes within mammography 
reporting and what evidence is there on their effectiveness?    
Secondary outcomes 
 To identify potentially useful data sources relating to individual 
characteristics of the arbitrator in terms of: education and training, 
experience, frequency and volume of images reported, and decision-making 
processes utilised. 




2. SEARCH TERMS 
Firstly, keywords and subject headings were collated into broad categories relating 
to the reporting process, personnel characteristics (e.g. experience, training, volume 
of films read), decision making and reflective practice, audit and Continuing 
Professional Development (CPD) (Appendix B).  These categories proved challenging 
as it soon became evident that they were too diverse and extensive. A decision was 
therefore made to refine the search strategy to make it more realistic and ensure 
achievable output within the time constraints.   
A comprehensive search strategy was formulated by establishing terms originating 
from the purpose statement (Kable et al. 2012).  Concepts of interest (Kable et al. 
2012 and Lloyd-Jones and Masterton 2010) were cross-referenced by searching 
Cochrane reviews for validation (Table 3 below lists the final search terms and 
variations used).  Developing a systematic search strategy initially proved difficult 
due to variable terminology and indexing across different databases (Derry, Loke and 
Aronson 2001).  Therefore, a combination of keywords, phrases, subject index terms 
(Thesaurus/MeSH) and the explode function were used.  Keyword truncation was 
also utilised to retrieve results that may have variations in the spelling, plurals and 
synonyms (Aveyard 2014).  Boolean operators ‘AND’, and ‘OR’ were applied to focus 
the most productive search and aid in eliminating inappropriate hits. 
To ascertain if the search terms were effective they were tested as recommended by 
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Kable et al. (2012) to establish if known key papers had been located. Greenhalgh 
and Peacock (2005) consider that highly structured search strategies across a range 
of electronic databases can still be unsatisfactory carrying the risk of missing 
relevant material which may be significant.  Betran et al. (2005) report that up to 20 
per cent of studies are not retrieved via database searching alone. Multiple studies 
(Timmins and McCabe 2005 and McGowan and Sampson 2005) advocate the use of 
an experienced librarian in literature searching.  In this study a librarian was utilised 
to check the search strategies for erroneous spellings or errors in the use of the 
Boolean operators. 
Table 3 Demonstrates the Final Search Terms and Variations Used 
 
  
Exploded terms Alternative keywords 
Breast neoplasm breast adj3 (neoplasm* OR carcinoma* OR tumour* OR tumor* 
OR cancer*. 
Mass screening breast adj3 (scan* OR screen* OR radiograph* OR imaging OR 
visualise OR visualize OR exam* OR test* OR mammogra* OR 
routine* OR check* OR diagnos* OR detect*) 
Mammography mammogra* adj3 (scan* OR screen* OR visualise OR visualize OR 
exam* OR test* OR breast*) 
Early detection of cancer  
National Health Service Breast 
Screening Program 
OR "NHSBSP" or "UK breast screen* program*" "NHS breast 
screen* program*" 
Negotiating arbitration* OR discordan* OR discrepan* OR disparity* OR 
negotiat* OR disagree* OR conflict* OR differen* OR 
inconsisten* AND variation* OR consensus* OR uncertain* 
Decision making "decision mak* OR shared decision making" OR "medical decision 
making" OR "choice behaviour" OR "problem solving" OR "clinical 
decision analysis" OR "critical think*" OR "decision aids" OR "Task 
performance and analysis" 
Interpersonal communication  
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3. SOURCES OF SEARCHES 
Databases/Electronic searches: In a scoping review the number of databases 
searched can be limited and this is recognised as a limitation of this type of review 
(Levac, Colquhoun and O’Brien 2010).  Seven databases were searched in the 
present study in an attempt to ensure relevant studies were not omitted (Crossan 
and Apaydin 2010). However, this proved a time-consuming process.  The Centre for 
Reviews and Dissemination (2008) has confirmed comprehensive-scoping reviews 
can take almost a year to accomplish.  The 7 databases were selected based on their 
relevance to retrieving multi-disciplinary research evidence from the perspectives of 
medicine, allied health professionals and health care.  A list of the databases 
searched is given in Table 4 below.  
Table 4 Databases searched and time frame for searches. 
 
In the above databases, search terms were restricted to title, abstract and keywords 
within the article or topic subject within Web of Science. A better understanding of 
Database Date range of search Appendices 
PubMed. No start date restriction -  
26th January 2016. 
See Appendix C for the full 
search strategy 
MEDLINE No start date restriction - to 
18th January 2016 
See Appendix D and E for the 
full search strategies 
 
EMBASE 1st January 2005 to 18th 
January 2016). 
See Appendix F and G for the 
full search strategy 
CINAHL  No start date restriction - 21st 
January 2016. 
See Appendix H for the full 
search strategy 
Cochrane Library  
 
No start date restriction -  
19th January 2016 
See Appendix I, J and K for the 
full search strategy 
Scopus 
 
No start date restriction -  
26th February 2016. 
See Appendix L for the full 
search strategy 
Web of Science  1st January 2005 to 26th 
February 2016 




the benefits of specific querying options led to the proximity operator of adjacent 3 
being used with search terms in order to retrieve terms within phrases and avoid 
onerous hits where breast was merely mentioned in the title. Rich Site Summary or 
Really Simple Syndication (RSS) feed alerts were set up on Scopus and Web of 
Science for keywords and citations of a current 2015 author; this ensured any 
updates would be known without the requirement to manually re-check.  Within the 
time limitations it was not possible to re-run all searches.  Therefore, an updated 
search (4th June, 2016) was undertaken in Scopus as this database had retrieved the 
greatest number of relevant papers.  Two further publications were identified that 
related to DBT and radiographer reporting, but neither were specifically looking at 
arbitration or consensus processes (Hodgson et al. 2016 and Culpan 2016).   
4. INCLUSION/EXCLUSION CRITERIA 
Criteria for including or excluding retrieved articles were devised to aid in the 
retrieval of significant studies and to minimise false positive search results (Bettany-
Saltikov 2010 and The Joanna Briggs Institute 2015). Criteria related to the 
intervention and population characteristics (Bettany-Saltikov 2010) but there was no 







Table 5 Inclusion and exclusion criteria 
5. SEARCH LIMITS 
The time frame chosen for the preliminary searches was publications between 1st 
January 2008 and 26th February 2016.  The rationale for the 2008 cut-off for this 
review was that it would give a 2-year lead in period from when relevant NHSBSP 
guidance was last revised (2010/2011). The final year 2016 was the year when this 
review was initiated and therefore represents the current position.  An English 
language restriction was applied to all searches for practical reasons.  This was not 
considered detrimental given the likelihood that high impact papers would be 
translated into English.  Searches were limited to human studies. 
Inclusion criteria 
 
1. Provides an English abstract or summary (to assess content) or the title explicitly 
demonstrates relevance 
2. Specifically mentions breast reporting arbitration, 3
rd
 reader or consensus processes 
OR 
3. Discusses reporting strategies – i.e. single reading, double reading, blinded or non-blinded 
reading.   
OR 
4. Reports strategies for management of discrepant cases – i.e. higher reader recall, arbitrate 
all recalls, arbitrate discordant cases only. 
OR 
5. Reports the grade of personnel undertaking the arbitration/consensus/3
rd
 read task i.e. 
radiologist, radiographer, clinician, surgeon 
OR 
6. Specifically, in relation to arbitration, 3
rd
 reader or consensus mentions any attributes 
required by the personnel undertaking the task.  In particular: 
Volumes of films read per annum, 
 Number of years’ experience of the reporter, 
Attendance at MDT’s,  
Decision making skills,  




1) Non English-language paper 
2) Arbitration, consensus or 3
rd





Initial searches on EMBASE retrieved small numbers of articles and scanning of the 
titles revealed that many appeared irrelevant.  Therefore, for subsequent searches 
either the start year was extended to 2005, or no date restriction was applied.  This 
also widened the ability to ascertain if a seminal piece of work was produced prior to 
the initial date limitation. 
Reference lists.   A manual search of reference lists in eligible articles was 
undertaken to look for any other relevant citations; one additional study was 
identified (Matcham 2004).  This was missed due to setting a 2005-year cut-off 
within two of the databases (see search limits).  Original searches by keywords and 
subject headings were supplemented with a search by key author names of articles 
published in 2015.   
Hand searching relevant journals. A search for key current articles published in the 
European Radiology and Breast journals was undertaken.  Both journals were 
searched with mammography and arbitration to see if any additional articles could 
be identified.  No further papers were sourced via this route. 
Grey literature.  A number of studies (Coad, Hardicre and Devitt 2006, Aromataris 
and Riitano 2014 and Mahood, Eerd and Irvin 2014) have described search methods 
and sources to locate grey literature.  However, Godin et al. (2015: 2) state that no 
‘gold standard exists for rigorous systematic grey literature search methods’ and 
their ‘transparency and reproducibility’ is frequently inferior to search methods 
reported from academic database searching.  Grey literature was sourced by hand 
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searching of conference proceedings and doctoral theses in an attempt to avoid 
positive publication bias (Goldacre 2012).  Conference proceedings were selected on 
the basis that their reporting was of breast imaging (UK or International perspective), 
and the National Cancer Research Institute (NCRI) was used as a means of the author 
thinking outside the box to ascertain if modalities other than imaging have 
transferable arbitration/consensus processes.  Searches were limited to 2014 
onwards as this allowed a 2-year lead in period for conference abstracts or posters 
to become a fully published article by 2016.  However, since the Society of Breast 
Imaging/American College of Radiology Breast Imaging Symposium (SBI/ACR) was 
inaugurated in 2015, 2014 papers/posters could not be retrieved.  Therefore, a 
review of the 2015 programme details only was undertaken. The NCRI cancer 
conference site proved difficult to search as there was only the option to keyword 
search and confinement by further filtering was not available.  Overall, searching of 
the grey literature was adaptable and time periods were flexed to available 
resources.  Only one poster presentation from the European Congress of Radiology 
(ECR) 2014 provided relevant information via this search method. 
Table 6 below documents the Grey literature search strategy.  English language 






Table 6 Grey Literature Search 
 
Internet searching. In addition to the academic databases searched, the basic 
keywords of mammography and arbitration were used to conduct a search on 
googlescholar.com. As it was not practical to screen all retrieved results from this 
search, reliance was placed on the Google search engine to list the most relevant 
results first.  It was notable that the Google search retrieved all key 2015 
publications that were subsequently only found in Scopus/Web of Science.   
Source Date range searched Keywords 
OpenGrey 
 
No date restriction- to 26th 
Jan 2016 
“Mammography and decision 
making”  
“Mammography and arbitration”  
“Mammography and reporting” 
OpenDOAR No date restriction- to 26th 
Jan 2016 
Mammography,  
“Mammography and breast 
screening” 
Ethos  No date restriction- to 26th 
Jan 2016 
“Breast Cancer” 
“Mammography and arbitration”  
“Mammography and consensus “ 
“Mammography and reporting” 
“Mammography and decision 
making” 
Zetoc Conference Proceedings 




“Mammography and arbitration” 
“Mammography and consensus” 
“Mammography and decision 
making” 
“Mammography and double reading” 
British Society of Breast 
Radiology  (BSBR) 
2015 
(2014 not available) 
 
European Congress of 
Radiology (ECR) 
2014 and 2015 
 
 
National Cancer Research 
Institute  (NCRI) 
2015 
2014 (unable to filter search 
terms) 
 
Society of Breast 
Imaging/American College 
of Radiology Breast Imaging 
Symposium  (SBI/ACR) 
2015 (Inaugurated)  
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Personal contacts. Godin et al. (2015) endorse that professional associates and 
experts in the field are useful contacts to source unpublished material. In accordance 
with this guidance key author of publications were contacted from the Netherlands 
and Germany to ascertain if they were aware of any research in progress or any 
upcoming publications relating to arbitration/consensus processes in mammography 
reporting.  The UK Royal College of Radiologists (RCR) and the Society and College of 
Radiographers (SCoR) were also contacted for assistance in locating relevant 
professional body publications.   
To improve the breadth of this element of the review method, the National Lead for 
Screening Quality Assurance (QA) Services at Public Health England was telephoned 
to widen the pool of contacts.  This led to further contacts being made with (i) the 
Editor-in-Chief of the Radiography journal who checked the editorial system to 
identify any accepted papers or those currently under review; (ii) the scientific 
supervisor for the Dutch Reference Centre for Screening; and (iii) the director of the 
National Retinopathy Screening Programme. Via these contacts the summary from a 
workshop in America was sourced which was primarily concerned with improving 
the interpretation of breast images.  Greenhalgh and Peacock (2005) describe this 
adaptable search method as snowball sampling where the strategy evolves with the 
information and sources retrieved in a receptive manner. These sources along with 
the British Association for Cytopathology were considered pertinent to the current 
review as they offered either an international perspective on screening or a 
comparator against which to benchmark breast-screening reporting processes. 
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6. DOCUMENTING THE SEARCH AND SELECTION PROCESS 
A series of sequential searches was undertaken with search queries and number of 
hits for each database documented; results were excluded if they retrieved zero 
results.  The complete process is demonstrated in the PRISMA diagram below (Figure 
5).   
 
Figure 5 PRISMA 2009 Flow Diagram 
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An important principle in a scoping review is to document and demonstrate the 
decisions made in order to show transparency of the search process (Aveyard 2014), 
which aids in reproducibility and validates the rationale. Studies were saved in an 
electronic folder and the online reference manager (EndNote) was utilised to 
remove any duplicates.  
7. TEST RELEVANCE OF RETRIEVED ARTICLES 
A three-stage process was utilised for filtering the array of published papers and grey 
literature retrieved (Bettany-Saltikov 2010). 
First stage: selection of literature for entry into review - First stage selection was 
undertaken based on an analysis of the titles and/or abstracts or summaries of all 
material identified through the various search strategies (Aveyard 2014). This 
resulted in exclusion of any papers/posters that were clearly not relevant and in the 
selection of potentially eligible articles, as well as determining the focus of the 
available literature. 
Second Stage: article/grey literature selection - In the second screening stage, two 
reviewers independently screened abstracts for all retained literature, against the 
agreed inclusion and exclusion criteria. Any disagreement was resolved after 
retrieval and review of the full text (five articles identified and arbitrated). 
Third Stage: Inclusion and exclusion criteria applied to full article - The full text of 
all potentially eligible peer-reviewed papers /grey literature items were retrieved.  
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Two reviewers independently examined these to determine whether the article 
provided sufficiently detailed evidence against the inclusion criteria, confirming that 
the abstract was not misleading. A third reviewer resolved any disagreements over 
the eligibility of a particular study (no articles identified).  
8.  SUMMARY TABLE OF INCLUDED ARTICLES 
Articles that met the inclusion criteria were documented in a customised data 
extraction form (Table 7) (Maslin-Prothero and Bennion 2010 and Cummings et al. 
2010).  This was designed to capture and summarise key information and major 
findings (The Joanna Briggs Institute 2015).  The data extraction form enabled raw 
data from multiple disparate studies to be amalgamated and compared, aiding in 
pattern recognition and providing a ‘rapid and succinct summary of the literature for 
review’ (Kable et al. 2012: 878). A decision was made to undertake data extraction 
separate to quality assessment in order to ensure that an overview of study details 
was available prior to concluding the overall judgement on quality.
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Table 7 Articles included in the review 
1. Klompenhouwer et al (a) (2015)  Netherlands – Quality CASP criteria met 
Research 
question/aim 








Main findings/results Strengths/ 
Weaknesses 
Effect of arbitration by 
a 3rd reader 
discrepant reading for 
blinded and non-























always recalled  
 
Retrospectively 




















3 units – 12 
radiologists, 1-15 






randomly assigned  
 
Recall rate, cancer 
detection rate, 
proportion of BI-





Cancers not recalled 
after arbitration by a 
third reader 




t- test. (95 % CI). Chi 
square and Fisher’s 
exact tests - 
differences in tumour 
and mammographic 
characteristics of the 
reading strategies, 
differences in surgical 
treatment.  
P-value < 0.05  
Discrepant readings =57.2 % blinded vs. 
29.1% non-blinded, (p< 0.001),  
Blinded double reading, arbitration=  
1. Decreased recall rate (3.4 to 2.2 %, p< 
0.001)  
2.decreased sensitivity (83.2 to 76.0 %, p 
= 0.013) 
3.No influence on cancer detection rate 
(CDR; 7.5 to 6.8 per 1,000 screens, p = 
0.258)  
4. Increased the PPV; 22.3 to 31.2 %, p 
<0.001).  
Non-blinded double reading, arbitration 
= 
1. Decreased recall rate (2.8 to 2.3 %, p < 
0.001)  
2.increased PPV (23.2 to 27.5 %, p=0.021) 
3.no affect on affected CDR (6.6 to 6.3 per 
1,000 screens, p=0.604)  
4.no affect on sensitivity (76.0 to 72.7 %, 
p=0.308).  
No differences in the proportion of DCIS, 
smaller tumours, lymph node 
Involvement or advanced tumours among 
SDCs and cancers missed at arbitration. 
 
Invasive cancers with axillary lymph node 
Weakness – 
Acknowledged by the 
author arbitration 
outcome did not affect 
“real-life”.  Discrepant 
cases were recalled 
regardless.  Therefore, 
the arbitrator’s role did 
not have clinical 





Waited 2 yr. screening 
period to capture 
“interval cancers”.  True 
sensitivity calculated.  
 
Prior films available 
 
Number of radiologists 
with variable 
experience reflects 
clinical practice  
 
Large case series 
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metastasis were less often seen among 
cancers 





et al (b) (2015) Netherlands - Quality  CASP criteria met  
Research 
question/aim 








Main findings/results Strengths/ 
Weaknesses 
Evaluate PPV, 
discrepant rate, and 
characteristics of BI-
RADS 0 recalls 
screening program. 
 
Determine the effect 
of arbitration by a 
3rd reader of 
discrepant BI-RADS 0 











on a monthly basis.  
Discrepant 
readings were 
always recalled  
 
Retrospectively 
















 July 1 
2011. 
 
3 units – 12 
radiologists 1-15 








Chi square or 




PPV of recall of BI-




arbitration by a 
third reader were 
calculated as 
interval cancers.  
 
Continuous 
variables - double 
sided t-test for 
independent 
samples 
P-value < 0.05 
Arbitration of discrepant BI-RADS 0 
recalls = lowered recall rate (from 3.4% 
to 2.8% at blinded double reading, p < 
0.001, and from 2.8% to 2.5% at non-
blinded double reading, p 1⁄4 0.008), 
without a decrease in cancer detection 
rate (from 7.5‰ to 7.3‰, p 1⁄4 0.751, 
and from 6.6‰ to 6.5‰, p 1⁄4 0.832, 
respectively) and program sensitivity 
(from 83.2% to 81.2%, p 1⁄4 0.453, and 
from 76.0% to 74.6%, p 1⁄4 0.667, 
respectively).  
Arbitration would have significantly 
increased the PPV at blinded double 
reading (from 22.3% to 26.3%, p 1⁄4 
0.015). 
13 cancers missed by arbitration - overall 
decrease in cancer detection rate is very 
small,  
0.1-0.2% at both reading strategies 
No differences in mammographic and 
tumour characteristics of BI-RADS 0 
Recall at blinded and non-blinded 
reading 
Weakness – Acknowledged 
by the author arbitration 
outcome did not affect 
“real-life”.  Discrepant cases 
were recalled regardless.  
Therefore, the arbitrator’s 
role did not have clinical 
implications for the 
screening. 
 
No cost-effectiveness  
 
 
Strengths– waited 2 yr. 
screening interval to 
capture “interval cancers”.  
Large case series 
 
Number of radiologists with 
variable experience reflects 




3. Hofvind et al (2009) Norway - Quality  CASP criteria met  
Research 
question/aim 


















Arbitration only if 
consensus not 












1, normal;  
2, probably benign; 
3, indeterminate;  
4, probably 
malignant; and  
5, malignant. 
Initial score of 2 or 
higher by either 
reader = a 
consensus meeting  
 
Initial score of 3 or 





Arbitration only if 
consensus not 
reached by initial 
reporters 
 1 033 870 prevalent and 
incident screens 
5611 screen detected 





experience = 4.3 years 
(range, 1–11 years), 
average volume for the 
whole study period (9 




SFM= 97%   
FFDM = 3%  
Differences in rates and 
proportions tested with a 
x2 test. All tests were two-
sided.  
P values <0.05. Logistic 
regression to estimate the 
odds that a discordant 
cancer was associated with 
mammographic density.  
Odds ratios (ORs) with 95% 
CI - adjustment for age at 
screening and prevalent vs. 
incident screening 
 K Statistics - for agreement 
between two readers. 
Unweighted K values for 2 x 
2 table analyses (positive 
and negative scores)  
Quadratic weighting for 
five-point interpretation 
scale.  
Observer agreement, k 
values < 0.20 =poor 
agreement; 0.21– 0.40, fair 
agreement; 0.41– 0.60, 
moderate agreement; 0.61– 
0.80, good agreement; and 
more than 0.81, very good 
agreement  
SPSS 
Discordant scores = 5.3% 
Concordant positive 
scores = 2.1%  
At consensus, 66.8% (36 
380 of 54 447) of the 
discordant and 17.9% 
(3932 of 21 928) of the 
concordant screenings 
were dismissed. Recall 
rate = 3.5% 
 
 23.6% (1326 of 5611) of 
CA had discordant 
interpretation. Varied 
from 16.9% (148 of 874 
cancers) to 28.6% (265 of 
928 cancers) according to 
county 
 
117 interval breast 
cancers were diagnosed 
among the 40 312 
screenings that were 
dismissed at consensus = 
6.5% of all interval 
cancers.  
 
Weakness – Acknowledged 
by author - Don’t know if 
score correlates with actual 
CA and if the 2 reporters 
recalled for the same 
abnormality as quadrant and 
lesion characteristics not 




2 radiologists read less than 
500 screening mammograms 
during 1 year in study 
period.  Against the 
exclusion criteria 
No cost effectiveness 
 
Strengths - 
Large case series 
Specialist and general 
radiologists – representative 
of a community setting, but 
no information provided on 
the amount of time non-





4.  James and Cornford (2009) UK. -  Quality  CASP criteria met  







Main findings/results Strengths/ 
Weaknesses 
Can computer-aided 
detection (CAD) act as an 
arbitrator of discordant 
double-reading opinions, 
replacing the need for an 










Not completely blind 
 
Original arbitration by 





and analysed by CAD 
system – compared to 
radiologist  
 
CAD algorithms set to 
operate at a detection 
sensitivity of 88% for 












5 radiologists, 1 






ranged - 5-18 yrs. 






to take into 
account the 
matched nature 
of the data. 
 
 Arbitration cases accounted for 22% 
(112/518) of total cases recalled for 
assessment. 
47% cases recalled to assessment 
following the opinion of the arbitrator 
21 cancers in arbitration set, 13 
diagnosed at the time of the original 
screening mammogram, 8 diagnosed 
subsequently. 3 were not the arbitrated 
lesion, 5 were – 2 of these were 
assessed and returned to RR.  CAD 
correctly prompted in these 5 cases. 
2 cancers recalled by arbitrator and not 
CAD 
Independent 3rd reader recalled 15/18 
(83%) of the cancers that corresponded 
with the arbitrated lesion.  
CAD as the arbitrator would have 
recalled 16/18 (89%) of the cancers that 
corresponded to the arbitrated lesion.  
CAD= significant increase in normal 
women being recalled to assessment in 
the arbitration group (P < 0.001).  Extra 
50 recalls. Recall rate increase from 3.1 
to 3.4%; increase of 10%. 
Overall –No. Of cancers detected were 
broadly similar with 1 additional cancer 










number of cancers in 
the series (18) 
 
Retrospective - can 
only give an 
indication as to the 
potential effect of  
CAD acting as an 
Arbiter 
 
No cost effectiveness 
 
Not completely 
blinded reading - 
may influence 






5.  Mucci et al   (1999)  UK - Quality  CASP criteria met  
Research 
question/aim 









Main findings/results Strengths/ 
Weaknesses 
Experience of 






























% Calculated for recall rates 398 arbitration cases - final 
reader recalled 196 (49%) and 
returned 202 (51%) to routine 
recall – 1 true interval CA 
subsequently 
Of 196 assessed - 4 malignant.  
Estimated cost saving by 
arbitration £20,000– 202 women 
returned to normal screening 
Assessment episode is £101, 3
rd
 
read=£1 (1999 figures) 
3
rd
 reader =reduction in no. Of 
recalls and no reduction in 
cancer detection. 
Weakness – acknowledged by 
author -non-blinded 2nd reader 
knew the opinion of the first and 
was influenced.   
Therefore, underestimate the  







 reader was aware of the 
opinion of the first two; simply 
asked to arbitrate on the action to 
be taken on an identified lesion – 
real clinical practice 


























% Calculated for Cancers 





 reader  
 
Total no. Of cancers 
detected through double 
reading 
 
The % of cancers detected with 
double reading + 3
rd
 reader 
arbitration varied each year -3.6 
and 11.4% 
 
Overall 87 (8.1%) of the 1072 
cancers were detected following 
3
rd








7.  Cornford et al  (2005)  UK - Quality  CASP criteria met  








Main findings/results Strengths/ 
Weaknesses 
Compare the mammographic 
background pattern, 
mammographic and pathological 
features of screen-detected cancers 
diagnosed following arbitration of 
discordant double reading opinions 
with cancers diagnosed following 













 reader arbitrator 
– had final decision. 
Independent 
decision – but not 
blinded to initial 
reports 







5 radiologists, 1 







18 yrs.  









such as patient age, 
was analysed with 
unpaired t-test with 
Stat- View 
 
287 malignancies.  38 (14%) 
had undergone arbitration 
and 249 (86%) had 
concordant double reading. 
 
50% of arbitrated cases were 
recalled for assessment -38 
malignant [PPV=18%].  
 
Arbitration cases accounted 
for 20% of the total recalls.  
Arbitration group – 1
st
 reader 
did not recall 27 
malignancies; 2
nd
 reader did 
not recall 11 malignancies.  
Arbitration group =27 
invasive cancers and 11 DCIS.  
Concordant group = 196 
invasive cancers and 47 DCIS. 
= No significant difference 
between 2 groups. 
 
No significant difference in 
proportion detected through 
a first or subsequent screen 
in the two groups (p<0.7).  
 
Cancers detected following 
arbitration were more likely 




 reader not entirely 
blinded – may affect 
cancer detection rates, 
but does reflect 
normal clinical 
practice.    
 
Only 2/5 radiologists 
as arbitrators 
 
Only 1-year f/u – too 









representative of UK 
practice, radiographer 







distortions p<0.001 and less 
likely to manifest as spiculate 
masses p<0.014).  
 
Less likely to be detected in 
fatty breasts p<0.01).  
 
Were smaller (p<0.045).  
 
Lobular cancers were 
commoner in the arbitration 




Estimated -11% more cancers 
are detected as a result of 
double reading with 
arbitration compared with 
single reading alone, after 
taking into consideration 




















Main findings/results Strengths/ 
Weaknesses 
Role of arbitration by 
3rd reader of 
discordant double 











 reader – only 



























test, p value 
<0.05. 
 
Recalls rate at double reading =6.8%. 230 (43.5%) 
were concordant + 298 (56.5%) were discordant. 
After arbitration classified – 216 (72.4%) negative 
+ 82 (27.6%) positive 
43 (18.6%) cancers were in concordant group 
6 (2%) discordant recalls 
5 were recalled 1 CA would have not been 
recalled 
Arbitration = reduced 216 assessment 
procedures (2.8% absolute, 40.9% relative 
reduction of recall rate) missed 1 CA (0.13‰ 
absolute, 2.0% relative reduction of cancer 
detection rate).  
Arbitration had a sensitivity of 83.3% 
Arbitration cost calculated as adding 3
rd
 reader = 
0.25 euros  
Assessment cost = 67.4–110.4 euros per 
Discordant readings, often resolved by additional 
views or ultrasound = lower cost to concordant 
recalls, more likely to require a biopsy. 
Based on above - Arbitration cost = 74 euros, 216 
spared assessment =14,558.4–23,346 euros. 
Bias adjusted for by doubling the cost per 
mammography reading to 0.50 euros and by 
reducing the cost per assessment procedure to 




Only 4-month period in study 
 
Only used 1 radiologist as the 
3
rd
 reader who had extensive 
experience >30yrs –not 
representative of the majority 
 
All cases were assessed and 
therefore the arbitrator’s role 
did not have clinical 





Author acknowledged, “some 
imprecision of cost estimates 




calculated from an excellence 
centre – does not reflect the 
average National scenario.   




9. Ciatto et al  (2005)  Italy - Quality  CASP criteria not met  
Research 
question/aim 






































9 radiologist readers  
7 radiologist arbitrators 
 
Experience - 
mammograms (at least 
10,000 mammograms 
read and at least three 







1217 discordant double readings 476 
cases (39.2%) arbitrated to assessment, 
detecting 30 cancers (6.3%).  
 
Of 741 negative arbitrations (60.8%), 
311 F/U thus far = 2 cancers (0.64%) 
occurred in the site previously 
suspected at one of the two 
independent readings.  
 
Assumed  
Arbitration sensitivity = 86.3% NPV 
99.3%.  
 
Arbitration reduced the overall referral 
rates from 3.82% to 2.59% (relative 
decrease 32.1%). false-negative 
arbitration, cancers detected per 1000 
women screened would decrease from 
4.58 to 4.50 (relative decrease 1.7%). 
 
2005 standards: cost per arbitration = 4 
euros, assessment 147 euros. 
 
For every 1 cancer missed due to 
arbitration - 151 recalls and 21,248 
euros would have been saved, whereas 
the saved cost per screened woman due 
to arbitration was 1.72 euros.  
Weakness - 
Only followed up 42% so far so 
estimated cancer detection rate. 
Rates transposed to full 
population screening to give the 
sensitivity/NPV recall etc. 
 
NOT continuous cases -limited to 
periods when radiologists were 






Strengths -  
Acknowledged by author - cost 
analysis cannot be generalized to 
any other setting, as costs may 
vary substantially from one 
country to another and possibly 
























for discordance,  
with CAD  
 
Invasive CA only 
Retrospect




1. Single read 
2.  CAD-assisted 
single 
Reading 
3.  Double 
reading  - 
blinded 
January 1998 to 
December 2001 
 
Total 1569 cases 
 
157 randomly selected 
double-read 
Invasive cancers were 
mixed 1:9 with normal 
cancers.   
 
2 Radiologists 
 Reader A - 
(>5000 cases/year) 7 
years screening 
experience 
Reader B - senior 
radiology 















sensitivities of 2 
reading methods -  
Stata ‘prtest’  
 








The CAD system was highly 
Sensitive (93%, 95% CI 87.8–96.5), 
detecting many cancers overlooked by 
the readers, but the readers rejected 
most TP prompts  
 
CAD prompts are numerous and mostly 
FP. 
 
BP sensitivity = 90.4%  
CAD+RA sensitivity =86.6% (P = 0.12) 
CAD+RB 94.3% (P = 0.14).  
 
CAD-RB specificity was less than BP (P = 
0.01).  
 
After CAD, reader’s sensitivity increased 
1.9% and specificity dropped 0.2% and 
0.8%.  
 
Arbitration decreased specificity 4.7%. 
 
ROC analysis = BP accuracy better than 
CAD+RA, borderline significance (P = 
0.07), but not CAD-RB.  
 
Cancers recalled after arbitration 




Prior mammograms were not 
available – may affect a 
reader’s decision to recall 
 
Relatively high ratio of 
cancers to normal cases in the 
test set 
 
Readers had no prior 
inexperience with CAD 
 
Don’t know what level of 
sensitivity the CAD system 
was set to. 
 
Only 2 readers utilised.   
Trainee as 1 of readers 
although sensitivity higher 
than experienced radiologist 
 
Strengths - 
Excluded cancer cases that 
were previously detected by 
the readers 
to eliminate bias due to 
recollection. 
 
Waited 2 yr. screening 
interval to capture “interval 
57 
 
No difference in cancer size or sensitivity 
between reading methods was found 
with increasing breast 
density.  
 
CAD-R and BP sensitivity and cancer 












11. Taylor and Potts  (2008) UK.- Quality  CASP criteria met  











Main findings/results Strengths/ 
Weaknesses 
Compare single reading 
with CAD to single reading 
without CAD 
 
Compare double reading to 
single reading 
 














Meta-analysis using the 
‘metan’ command in Stata 8.2. 
 
Becker–Balagtas 
marginal estimated odds 
ratios 
 




models (DerSimonian and 
Laird method) when 
heterogeneity as high. 
Heterogeneity within each of the 
groups for recall rates.  
Arbitration/consensus studies, p < 
0.001 
 
Overall, arbitration studies show a 
decrease in recall rates, but two, 
including one of the largest studies, 
show a significant increase. 
 
Double reading – recall rates with 
arbitration - overall pooled 
estimate for the odds ratio is 0.94 
(95% CI: 0.92, 0.96; v2 (1) = 30.1, p 
< 0.001). As a risk difference, this is 
a reduction of 2.67 per 
1000 (95% CI: –1.72, –3.62; z = 
5.49, p < 0.001).  
 
Random effects models - pooled 
estimate for arbitration/consensus 
studies is lower, but a larger 
confidence interval means that the 
result is marginally not significant 
(OR = 0.87; 95% CI: 0.75, 1.02; z = 
1.67, p = 0.095). 
 
Double reading with arbitration 
increased detection rate 
Strengths - 
 




(confidence interval (CI): 1.02, 
1.15) and decreases recall rate (CI: 
0.92, 0.96).   
 
Double read – cancer detection 
rates with arbitration/consensus – 
overall pooled estimate for the 
odds ratio is 1.08 (95% CI: 1.02, 
1.15; V 2(1) = 6.2, p = 0.012) and 
the risk difference is 0.44 per 1000 
(95% CI: 0.10, 0.79; z = 2.50, p = 
0.012). 
 
For double reading with 
arbitration, the number needed to 
treat is 2222 women screened for 
each additional cancer detected. 
 
CAD does not have a significant 
effect on cancer detection rate (CI: 
0.96, 1.13) and increases recall 
rate (95% CI: 1.09, 1.12).  
 
Evidence that double reading with 
arbitration enhances screening is 
stronger than that for single 






12.Groenewoud et al  - (2007) Netherlands - Quality  CASP criteria not met  
Research 
question/aim 







Main findings/results Strengths/ 
Weaknesses 
Compare reporting 
strategies – cost 
effectiveness 
 
1.decision by one of 
the readers 
2. Refer if both agree 
(consensus) 












2.double reading with 
referral if any 
Reader suggests  
3. Double reading with 
referral only if both 

























Double reading with referral if any reader 
suggests resulted in a 1.03 times higher 
sensitivity (76.6%) and a 1.31 times 
higher referral rate (1.26%) than double 
reading with consensus.  
 
Figured assumed – extrapolated 
Assuming a relative increase of the 
detection rate by 2% and a relative 
increase of the referral rate by 30% double 
reading with referral if any reader suggests 
is comparably cost-effective to double 
reading with consensus 
(e 2,168 and e 2,207 per life-year gained, 
respectively). 
 
Control cases concordant =90.2% 
89.4% both readers=normal case.  0.8% 
they both recommended referral.  
Cases concordant =75.2% 
59.3% both readers=normal case 
15.9% they both recommended referral. 
Of all readings by the 153 radiologist pairs, 
17.7% were discrepant. 
Referral rates were highest with decision-
making by consensus =73.8% decision by 1 
reader = 57.4% arbitration = 52.7%  
Weakness - 
Experimental setting not 
reflective of daily practice 
 
Used published regional 
Data to estimate the 
distribution of concordant 
and discrepant readings 
 
Assumed that each referral 
of a case would lead to the 








13. Lång et al (2016) Sweden - Quality  CASP criteria met  
Research 
question/aim 























Double reading and scoring 
 
Arbitration = at least two 
readers decided on recall 
irrespective of the score on 
the other modality 
 
Conventional 2 view DM 
 
1 view (MLO) DBT 




Aim for 15,000 this 
study reports first 
half - 7500 cases 
 
6 radiologists 
5 = > 10 years’ 
experience 
1 reader =< 10 years’ 
experience 
Mean 26 years, 
range 8 to 41 years)  
 
Individual training in 
interpretation of 
DBT images 
McNemar's test for 
paired data of DBT and 
DM screens for 
differences in 
detection and recall 





detected solely by DBT 
and all 
DM-detected cancers 
tested using chi-2 test 
and Fisher's 
Exact test, if the sample 
size was small.  
 






Recall rate after arbitration 
was 3.8 % (3.3 to 4.2) for DBT 
and 2.6 % (2.3 to 3.0) for DM 
(p<0.0001). 
The PPV was 24 % for both 









Interim analysis  - 
does not have 80% 





14.Duijm et al, (2004) Netherlands - Quality  CASP criteria met  







Main findings/results Strengths/ 
Weaknesses 
Determine the value of 
arbitration by a panel for 














between 2 readers.  
Persistent discordance 
went to  
arbitration panel = 3  
Radiologists different 
to original reporters 
 
Referred to 





3 panel radiologists 
aware of discordant 
reads but 
Blinded to results of 
the other arbitration 
panellists. 














varied from 15 to 36 
months (mean, 
31 months). 
% Or recall 
rates, cancer 
detection rates  
Concordant referral = 498 (0.8%) of 65,779 
screened  
Concordant normal = 64,949 (98.7%) women.  
 
Initial Discordant = 
332 (0.5%) cases.  
 
After a mutual consultation, disagreement 
persisted  
183 (0.3%) mammograms.  
 
Arbitration panel referred 89 of 183 cases.  CA = 
20 (22%) cases.  
 
 3 (3%) of the 94 not referred by the panel, 
breast cancer was detected at the site of 
previously discrepant mammographic findings 
seen at subsequent screening performed 
2 years later. Arbitration panel missed 
 
If all 183 discrepant cases had been referred, 
the referral rate would have increased from 
0.8% to 0.9% at subsequent (incident) 
screenings and from 1.5% to 1.7% at initial 
screenings.  
 
At subsequent screenings, the number of 
cancers detected per 1,000 women screened 




















15. Khoo et al  (2005)  UK   - Quality  CASP criteria met  









Main findings/results Strengths/ 
Weaknesses 
Recall and cancer detection 
rates with and without 
computer-aided detection 











Double reading - by at 
least 1 radiologist 
 
Each reader viewed 
current and available 
prior mammograms for 
each case – recorded 
an opinion 
 
CAD prompts for the 
current mammograms 
displayed - reader  
reassessed the 
prompted areas before 
recording a revised 
assessment 
 
Arbitration cases - 
discussed by an 
additional 2 consultant 
radiologists 
 reviewed current/prior 
images, CAD prompts, 
and proforma  
March 21, 2003, 
and January 9, 
2004,  
 






12 readers – 7 
radiologist + 5 
radiographers 
 
4 to 23 years’ 
experience -  
Mean of 11 years 
Relative sensitivity 
was calculated for 
each of three 
protocols (i.e., 
single reading, 
single reading with 
CAD, and double 
reading) 
 





Estimates for the 




time taken and 
number of cases 
arbitrated 
over a 3-week 
period 
62 CA detected. 
 
CAD prompted 51 
(84%) of 61 radiographically 
detected cancers.  
 
Of 12 cancers missed on single 
reading, 9 were correctly prompted; 




Single reading was 90.2% 
Single reading with CAD was 91.5%  
Double reading without CAD was 
98.4%  
 
1639 cases arbitrated 
39% recalled to assessment 
61% - routine recall 
 
More women were allocated to 
arbitration when mammograms 
were read with CAD -13.8% to 
10.5% non CAD 
More women were recalled for 
assessment in the CAD group -6.1% 
to 5% non-CAD 




available if possible 
 
Weakness - 
The sensitivity the CAD 
system was set to is not 
mentioned 
 
True false-negative rate – 
can’t be calculated 3 
years of follow-up 
needed. Unable to assess 
if any cancers were 
arbitrated to normal and 







16. Posso et al (2016) Spain - Quality  CASP criteria met  









Main findings/results Strengths/ 
Weaknesses 
Costs and health-related 
outcomes of double versus 
single reading of digital 




Arbitration and consensus 











arbitration by  
3
rd















Test, and Fisher 
exact test. 
Statistical tests 
were two sided 





(2011) and IBM 
SPSS software 
version 




Discordance between radiologists in 
4.5 %(N= 2,556) cases 
  
98.1 % (N= 2,508) resolved 
by consensus and  
 
1.9 % (N = 48) by arbitration 
 
Estimate affect 
Cost. Double reading without consensus 
and arbitration was 
14 % (€ 36,341) more expensive than 
double reading with consensus and 
arbitration. 
 
Health-related outcomes. Double 
reading without consensus and 
arbitration had 1.5 % more false positive 
results than double reading with 
consensus and arbitration (p < 0.001). 
Both reading strategies had similar 
cancer detection rates (p = 0.986).  
 
Double reading with consensus and 
arbitration was 15%(Euro 334,341) more 
expensive than single reading with first 
reader only.  
False-positive results were more 
Weakness - 
No interval cancer 
rates -results are 
not conclusive  
 








frequent at double reading with 
consensus and arbitration than at single 
reading with first reader only (4.5 % and 
4.2 %, respectively; 
P <0.001).  
 
Single reading could reduce the 
frequency of false positive results 
without changing the cancer detection 
rate. 
 














Main findings/results Strengths/ 
Weaknesses 
Compare double 




























April 1991 -July 
1999 
 









 Consensus or arbitration or a mix of the two, decreased recall rates 
(by between 61 and 269 per 10,000 women screened). 
 
Insufficient evidence was available to detect any pattern in cancer 
detection according to recall policy. 
 
Specificity increased with consensus or mixed recall. 
 
Unable to analyse cost effectiveness as significant variation between 
the organisation of services from different countries 
 
Unable to quantify a difference on cancer detection rates from the 
results. 





18. Skaane et al (2013) Norway- Quality  CASP criteria met  
Research 
question/aim 















PPV for women 
recalled after 
arbitration, and the 
type of cancers 
detected 
with use of FFDM 




























November 22, 2010, to 









Images scored 1-5 
One score of 2 or 
greater in at least one 
arm were discussed at 
arbitration before a 
consensus-based 




meetings = min 2 
radiologists 
Analyses were 
based on marginal 
log linear models 




and adjusting for 
reader-specific 
performance 






rates, false positive 
rates before 




False-positive rates before 
arbitration were 61.1 per 
1000 examinations with 
mammography alone and 53.1 
per 1000 examinations with 
mammography + tomosynthesis 
(15% decrease, adjusted for 
reader; P, .001).  
5 of 8 radiologists referred 
proportionally more patients for 
arbitration with use of 
mammography alone than with 
use of mammography + 
tomosynthesis. 
 
Overall number of women 
recalled as a result of arbitration 
was larger for those initially 
assigned a 
positive score at mammography 
+ tomosynthesis (351 vs. 
265 women). However, the 
concordant increase in the 
detection of 24 additional 
Cancers resulted in a similar PPV 
for the cases ultimately recalled 
after arbitration 
(29.1% mammo alone and 28.5% 
+ tomo)  
 
Weakness - 
Only limited data about 
interval cancers -cannot 
estimate conventional 
absolute sensitivity or 
specificity.  Estimate relative 
performance levels  
 
Potential candidates were 
selected on the basis of 
whether technical staff 
members and imaging 
systems were available to 
perform the additional 






19.  Wolf et al (2015) Germany -Quality CASP criteria met 
 
 







Main findings/results Strengths/ 
Weaknesses 
Performance of 3 collective 
intelligence rules (“majority”, 
“quorum”, and “weighted 











182 test set cases 
Images from  





into sizes (range: 
1 to 15) 
Average true and 
false positive rate of 
the no. of 
radiologists 
determined by a 




Weighted quorum  
As group size increased, all 
three CI rules achieve 
increases in true positives 
and decreases in false 
positives.  
 
Larger groups made more 
accurate decisions 
 
Marginal affect when group 
size exceeds 9 relatively 
small group sizes achieved 
performance improvements 
 
Overall decision accuracy = 
Weighted quorum rule 
slightly outperforms the 
quorum rule and that the 
quorum rule outperforms 
the majority rule 
 
Strength - 
Large number of 
radiology participants – 




system of consensus 
without ‘over-ruling’ of a 
group face-to-face 
setting.   
 
Weakness –  
Test set, no influence on 






20.  Blanks et al (1998) UK - Quality CASP criteria not met (No for Q6 against cohort study) 
 
 








Main findings/results Strengths/ 
Weaknesses 
Cancer detection rates for 
different reading strategies. 
Breast screening 
 
Consensus and arbitration 
Observational 




1. Single reading 
2. Double reading (with recall 
if any reader suggests) 
3.double reading 
(With recall if both readers 
agree, consensus) 
4. Double reading (with 
arbitration by a third or more 
radiologists) 
5. Double (complex) 















Prevalent screen  
Double (consensus) = 
1.26 SDR 
referral rate = 6.8 
Double (arbitration) = 
1.28 SDR 
Referral rate =7.3 
 
Incident screen invasive 
cancer SDR - 
Double (consensus) = 
0.98 SDR 
Referral rate = 3.1 
Double (arbitration) = 
1.10 SDR 
Referral rate =4.0 
 
Incident screen invasive 
cancer SDR <15 mm 















21.  Skaane et al (2013) Norway - Quality  CASP criteria met  
Research 
question/aim 







Main findings/results Strengths/ 
Weaknesses 
Compare double 














5-point rating scale for 
probability of cancer: 







Scores of 2 or greater in at 
least one reading arm 
=discussed at 
arbitration, with at least 
two radiologists  
 
Consensus-based decision 
for all cases with a 
least one rating of 2 or 3.  
 
Cases with a score of 4 or 5 
were recalled and could 





8 Radiologists -  2–
31 years of 
experience (average 





Type III test -in 
generalised linear 
mixed Model  




addressed using G-side 
random effects 
74% of mammo only cases – 
returned to routine recall at 
consensus. 26% recalled.  75% 
of these negative at assessment 
 
61% of mammo +tomo – 
returned to routine recall at 
consensus.  39% recalled.  74% 
of these negative at assessment 
 
Pre-arbitration false-positive 
scores were 10.3 % mammo 
only and 8.5 % for 2D+ 
3D (P<0.001).  
 
Recall rates were 2.9 % 





Mammo only before 
arbitration= 6.5% after = 24.7 %  
2D+ 3D before arbitration= 10% 
after = 25.5 % 
 
Strength - 
Scores recorded directly 
into the NBCSP database 
-results locked at the 
end of each reading 
 
Weakness - 
Unable to assess 
outcome of cases 
dismissed at arbitration 







22. Hukkinen et al (2006) Finland - Quality CASP criteria not met 
 
 











Main findings/results Strengths/ 
Weaknesses 
Conference consensus (the  




Independent reading of 
several radiologists (the 
positive opinion of at least a 








consensus = the 
majority opinion in 
the group 
 
1997 – 2001 
 
200 Test cases 
4 radiologists  
 





radiologists,   
 
2 residents, 







The greatest sensitivity of 
74.5% = readings of the four 
best-performing readers were 
combined.  Sensitivity very 
variable 
 
Sensitivity maximal when any 
positive opinion within a pair or a 
group of readers is taken into 
consideration.  
 
Conference reading  = improved 
specificity  
Weakness - 
Small number – test cases 
 
High ratio 1:4 cancers to normal 
cases – not representative of 
normal practice 
 
Actual consensus where 
Readers discuss discordant findings 
did not happen in order to avoid a 
situation in which one reader is 
overruled by another.  
 




















Main findings/results Strengths/ 
Weaknesses 
Affect of consensus on 






Consensus for all 




April 1997 - 
March 2002.  
2 years prior to the start of 
the consensus meeting, 
and the 3 completed years 
since. 
 
3 radiologists – 3-12 yrs. 
Experience 
 







5% of screening cases discussed at 
consensus meeting (n=2637) 
 
65.6% recalled after consensus  
 
3 interval cancers subsequently 
diagnosed after RR outcome 
following consensus – 1 true and 2 
minimal signs 
 
97 (10.7%) of the women returned 
to routine screening had been 
marked for recall by both original 
film readers. 
 
Consensus of all cases - Reduction in 
recall rates  
 
Increase in Specificity  
 
Strength -  
 
Sufficient follow-up 
period to assess interval 























Main findings/results Strengths/ 
Weaknesses 
Assess differences in 
the film-reading 










Not completely Blind 
reading 
 
Arbitration by 3rd 
reader – radiologist – 
not blinded has access 
to previous opinions 
2004 -2007 
4 programmes 
within the East 
Midlands 
 







intervals, and chi 
square 
 
Tests with Monte 
Carlo simulation. 
Double reading= discordance in 13,279 cases 
(5%) underwent arbitration. 
 
 9726 (73%) were returned to routine rescreen, 
3553 (27%) were recalled 
 
PPV for unanimous recall = 22.7%  
PPV for recall following arbitration = 8.3%  
 
4.1% of interval cancers with no previous recall 
outcomes were false negatives, which was 
significantly lower compared to the groups 
where at least one reader had indicated recall 
(10.9%; p. 0.005).  
 
Cancers detected at the subsequent screen 
demonstrated no significant difference in 









































Consensus panel = 




one or both of the 
original readers.  
 
Recall -if any 






5 radiologists  














Z test (95% CI 
P<0.05 
 
Discordant cases = 1.04% 
 
After consensus, 45.39% recalled  
 
 11.7% of these were cancer 
 
Highest reader recall = could 
potentially increase the cancer 
detection rate by 0.6 per 1000 
women screened but would 
increase the recall rate by 12.69% 
and the number of 
False-positive findings by 15.37%. 
 
Conclusion: The consensus panel 
identified 71 (7.33%) of 968 cancers 
diagnosed. Consensus review 
substantially reduced the 
number of cases recalled and was 
associated with a low false-negative 
rate. 
 




44 (6%) cases at consensus sent to RR 
with no follow-up. 
  
False-negative findings was predicted 
by multiplying the number of patients 
who did not return for a follow-up 
visit (n -44) by the percentage of 
false-negative findings in patients 
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9.  RETRIEVED ARTICLES AT END OF THE SEARCH PROCESS 
A total of 715 articles were retrieved for review following publication database and 
grey literature searching. Excluding duplicates 601 remained. A large proportion of 
duplicates were the result of searching multiple databases (see PRISMA diagram).  
558 of the 601-articles/grey literatures were excluded, as they did not meet the 
selection criteria, leaving 43 for full-text review.   
10. QUALITY APPRAISAL OF RETRIEVED ARTICLES 
Armstrong et al. (2011) and Booth, Papaioannou and Sutton (2012) state that 
scoping reviews do not usually undertake quality appraisal.  However, Levac, 
Colquhoun and O’Brien (2010) assert that a lack of quality assessment may result in 
false conclusions about the issue and extent of gaps within the evidence.  This view 
is supported by McDermott et al. (2013) for narrative reviews, which they state, can 
also be deemed less reliable if quality assessment is not made clear.  
Critical appraisal tools provide a systematic method of pulling out pertinent 
information from studies and allow the reader to determine how strong the 
evidence is and relevance to their clinical practice.  Of the retained papers quality 
assessment for methodological rigour was undertaken using criteria derived from 
the standardised Critical Appraisal Skills Programme (CASP) questions (2013) where 
appropriate (Appendix N).  Some articles reported audit results, which were not 
amenable to CASP analysis.  Quality appraisal of the included studies was 
undertaken independently by two reviewers, and in cases of disagreement, a third 
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reviewer was consulted with the aim of reaching consensus through discussion. 4 of 
the 43 papers were excluded after quality assessment, as there was insufficient 
evidence of reliability to warrant inclusion.  No weighting or ranking of the papers 
finally included was undertaken.  
11.  CRITICAL REVIEW PROCESS 
The critical review involved two distinct phases of data extraction and synthesis. 
Data extraction. The main reviewer only undertook this process. This is recognised 
to introduce a possible level of subjectivity. Data extracted included: 
 Article descriptors: author; year of publication; country where study performed;  
 Study context (screening versus diagnostic);  
 Sample size;  
 Data analysis/metrics; 
 Reporting strategy (double reading; blinded or non-blinded reading);  
 Use of a test set versus prospective series of patient selection;  
 Strategy utilised for discordant results;  
 Readers (professions, number acting as arbitrator, years of experience, and 
specific training in mammogram reading); 
 Strengths and weaknesses of the study. 
The retrieved data was synthesised to address the primary and secondary outcomes. 




Synthesis.  The findings were summarised in a thematic narrative synthesis. Popay et 
al. (2006: 5) define this as: ‘An approach to the systematic review and synthesis of 
findings from multiple studies that relies primarily on the use of words and text to 
summarize and explain the findings of the synthesis’. Due to the heterogeneity of 
studies found, this method was deemed most appropriate for the present scoping 
review. 
3.2 Chapter 3 Summary 
This chapter has described the methods used and justified the need for a scoping 
review to address the research questions posed.  It has summarised the key steps to 
undertaking a scoping review as advocated by Popay et al. (2006).  A large volume of 
papers (601) were identified initially and following the screening, full text review and 
quality assessment this led to 26 being retained for the final review. The following 




Chapter 4. Results 
This chapter details the results of the evidence found for the scoping review on 
arbitration or consensus processes within mammography reporting.   The chapter 
explores evidence on the effectiveness of different strategies utilised to resolve 
discordance in breast screening reports and discusses key features of the evidence, 
emerging themes, relationships and disparities between studies with generalizability 
discussed relative to UK practice. 
4.1 Results of the Search 
Of the 43 full text papers reviewed, 26 studies provided sufficient data for this 
systematic scoping review (Data extraction Table 7). The PRISMA flow chart 
demonstrates that 13 were excluded at full-text review, reasons for this were: 
 No outcome of interest (n=7) 
 No relevant data (n=6) 
A further 4 papers were excluded following quality appraisal.  Reasons for exclusion 
were: 
 Historical data used as a comparator to CAD (n=1) 
 Probability of the affect reported (n=1) 
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3 independent readers classed as the equivalent of double reading with arbitration 
(n=1) 
No outcome in 37.4% of the cases (n=1) 
 
4.2 Included Studies 
The retained studies consisted of a mixture of designs, but all were quantitative in 
nature.  No qualitative studies were retrieved on arbitration or consensus processes.  
There were eight studies (Table 7 studies 1,2,3,4,7,10,12,16) described by authors as 
retrospective and twelve (Table 7 studies 5,8,9,13,14,15,18,19,21,22,25,26) studies 
were prospective, with one (Matcham et al. 2004) a mixed design of retrospective 
and prospective cases. The remaining study characteristics comprised of two audits 
(Liston and Dall 2003 and Jenkins et al. 2014), two systematic reviews (Taylor and 
Potts 2008 and Dinnes et al. 2001) and one observational epidemiological study 
(Blanks et al. 1998). However, only five of the prospective studies (Mucci et al. 1999, 
Caumo et al. 2011, Ciatto et al. 2005, Shaw et al. 2009 and Duijm et al. 2004) were 
predominantly looking at the effect of arbitration or consensus, the remainder 
focused on the transition from screen film mammography to digital mammography 
(Skaane et al. 2007), comparison of current reading protocols to CAD assisted 
reading (Khoo et al. 2005), impact on the number of readers (Hukkinen et al. 2006, 
Wolf et al. 2015) and comparison of conventional FFDM with tomosynthesis (Lang et 
al. 2016, Skaane et al. 2013a and Skaane et al. 2013b).  Two systematic reviews 
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(Taylor and Potts 2008 and Dinnes et al. 2001) were incorporated but their primary 
remit was comparison of reading strategies i.e. double reading with single reading, 
and single reading with and without CAD.  
4.3  Data Extraction of Study Features  
Table 7 summarises the pertinent characteristics of the included studies. The 
features extracted from each publication were authors, year of publication, country, 
study design, research aim, sample size, characteristics of the participants, duration 
of the study, reporting/arbitration strategies, data analysis/metrics, main findings, 
and strengths/weaknesses. Significant differences amongst studies were found for 
all characteristics considered. 
4.3.1 Publication Date 
Publication dates ranged from 1998 to 2016, with two studies (Klompenhouwer et al. 
2015a and Klompenhouwer et al. 2015b) both within 2015 consider the same cohort 
of patients, but are published as two separate sub-studies, although arbitration was 
the primary focus of both.  The number of studies published per year varied from 0-4, 
with the peak number in 2009 (n=4).  It is therefore notable that a number of studies 
have been undertaken prior to the start of the digital transition in 2006. 
4.3.2 Country of Publication 
Publications have predominantly been from the UK (n=11) with the last publication 
being a 2014 audit; prior UK studies relate to 2009 or earlier.  The remaining 
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publications were from the Netherlands (n=4), Norway (n=4) and Italy (n=2) with one 
publication from each of Australia, Finland, Sweden, Spain and Germany.  Again, two 
of the Netherlands studies (Klompenhouwer et al. 2015b and  Klompenhouwer et al. 
2015a) represent the same cohort of patients and study period. 
4.3.3 Characteristics of the Readers 
There was variability in both the experience and cohort of professionals’ undertaking 
the reporting process. In those studies, where information was provided, radiologists’ 
experience is given as a range, which varied from 15 months screening experience to 
more than 30 years.  Five studies incorporated radiographers as film readers but this 
would be consistent with the UK only, who utilise this cohort of staff as a reporter 
and only one of these papers was a fairly recent (2014) audit. James and Cornford 
(2009) represent the latest research study, which incorporated one radiographer as 
a film reader.  Radiographer reporting is now commonplace in the UK with a number 
of units utilising double radiographer reporting following the NDROR trial in 2012 
(Bennett et al. 2012).  Therefore, no recent arbitration or consensus studies were 
found reflecting this change in reporting personnel. Two studies (Cornford et al. 
2005 and James and Cornford, 2009) incorporated research fellows within the 
reporting group, one study (Shaw et al. 2009) included two consultants who had just 
completed fellowship training, a further study (Cawson et al. 2009) utilised a senior 
radiology trainee with 6 months training, and one study (Hukkinen et al. 2006) 
included 2 general radiologists and 2 residents (equivalent to a UK House Officer). 
Internationally, specialist and general radiologists are representative of the 
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workforce reporting screening mammography, which is disparate to current UK 
practice. 
4.3.4   Population/Sample Size 
All studies were within population-based national or regional screening programmes.   
Sample sizes within the studies ranged from 182 test set cases to a retrospective 
review of 1,033,870 prevalent and incident screens.  Study duration varied greatly 
dependent on study design ranging from a 4 month prospective study (Caumo et al. 
2011) to a 9 year retrospective study (Hofvind et al. 2009).   
4.3.5 Test Sets 
Five studies utilised test sets (Cawson et al. 2009, James and Cornford 2009, 
Groenewoud et al. 2007, Wolf et al. 2015 and Hukkinen et al. 2006). A weakness 
identified by the authors James and Cornford (2009) was that although 240 real 
arbitration cases were utilised to test the effectiveness of CAD as an arbiter, using a 
small number of test cases meant there was only a small number of cancers (18) in 
the series.  The other four studies circumvented this by weighting the test sets with 
relatively high ratios of cancers to normal cases; however, this therefore does not 
reflect the normal screening scenario. In clinical practice readers need to report 
relatively large quantities of films before a positive cancer case is read.   
4.3.6 Double Reporting - Blinded and Non-blinded 
Not all studies detailed the percentage of cases in which double reading produced 
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discordant results, but from the data available there was a large variation ranging 
from 0.5% (Duijm et al. 2004) to 57.2 % (Klompenhouwer et al. 2015a) of cases. 
Klompenhouwer et al (2015a) demonstrated that there was a significant difference 
in the number of discrepant reads dependent on whether the double reading was 
performed blinded (57.2%) vs. non-blinded (29.1%). This raises the question as to 
whether some of the blinded-reading studies are truly blinded. The UK authors 
acknowledged that readers were not completely blinded as only one set of 
assessment paperwork is commonly utilised.  Upon completion of the reading batch, 
the 2nd reader is required to amalgamate the paperwork and hence will be aware of 
the 1st reader report and any discrepancies.  This therefore presents the potential for 
the 2nd reader to review the case and change their opinion.  This may subsequently 
affect an individual’s cancer detection rates.  
4.4 Arbitration Studies 
Although twelve studies (1,2,4,5,6,7,8,9,10,13,18,24) mentioned arbitration within 
the reporting process only five studies (1,2,5,8,9) were specifically looking at the 
effectiveness of the arbitration process, with one study reporting the affect of CAD 
acting as an arbiter (James and Cornford 2009).  Within other studies arbitration 
occurred as part of normal clinical practice but the main focus of the studies was 
evaluating CAD performance, tomosynthesis, film reading histories or assessing the 
mammographic and pathological features of screen-detected and interval cancers.  
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4.4.1 Effect of Arbitration on Recall Rates 
In those studies, that provided the information, the final decision of the arbitrator 
resulted in wide variation as to whether cases were ultimately recalled or discharged 
back to routine screening.  In the Jenkins et al (2014) study 27% of cases were 
recalled to assessment following arbitration but in the Cornford et al (2005) study 
50% of cases were recalled. There was a comparable variation in cases returned to 
routine screening following arbitration ranging from 50% (Cornford et al 2005) to 
72.4% of cases in the Caumo et al (2011) study.   
Overall, studies reported that compared to highest reader recall (non-arbitration), 
arbitration resulted in significant reductions in recall rates, with relative decreases in 
the range of 17.8% (Klompenhouwer et al 2015b) to 40.9% (Caumo et al. 2011).  
Although Caumo et al (2011) report one of the highest reductions in recall rates by 
arbitration, the results must be interpreted with caution as this study was conducted 
over a short (4-month) period, with a single experienced (>30yrs) individual arbiter. 
All cases were recalled to assessment irrespective of the arbitrator’s decision, and 
therefore there was no direct impact on clinical care.   Variability in reducing recalls 
is also confirmed by Liston and Dall (2003) reporting findings from a seven-year audit. 
Klompenhouwer et al (2015a) assert the reporting strategy (blinded vs. non-blinded) 
also has a significant effect on sensitivity following arbitration.  Although no effect 
on sensitivity was reported at non-blinded reading, blinded reading with arbitration 
demonstrated a statistically significant decrease in sensitivity (83.2 to 76.0 %, p = 
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0.013). With such variation in recall rates the PPV of assessment cases following 
arbitration is also unpredictable with low PPV’s of 8.3% (Jenkins et al. 2014) to 
31.2 % (Klompenhouwer et al. 2015a) reported.   
There is disparity between the studies regarding the effect of arbitration on cancer 
detection rates.  Klompenhouwer et al (2015b) declared an overall decrease, albeit it 
small (0.1-0.2%) and not statistically significant, whilst the systematic review by 
Taylor and Potts (2008) stated double reading with arbitration increased cancer 
detection rates. Dinnes et al (2001: 458) systematic review affirmed there was 
‘insufficient evidence to detect any pattern in cancer detection based on recall policy’. 
The scoping review highlighted that within the five studies (1,2,5,8,9) specifically 
looking at the effectiveness of the arbitration process, two studies were 
retrospective analysis (Klompenhouwer et al. 2015a and Klompenhouwer et al. 
2015b) and although Caumo et al (2011) was a prospective design, assessment was 
performed irrespective of the arbitration decision. Methodological weaknesses were 
also identified in the Caumo et al (2011) study which was undertaken over a short 4-
month period, and utilising only 1 radiologist as the arbitrator who had extensive 
experience (>30yrs).  The James and Cornford (2009) study was unique in using CAD 
as a means of assisting interpretation where discrepant lesions had already been 
identified by one of the initial readers.  The decision of CAD as the arbitrator was 
retrospectively compared with the decision of the original third independent reader 
and hence like the Caumo and Klompenhouwer studies the results can only 
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hypothesise the effect of the arbiter because the outcome did not affect real care.    
Therefore, it is difficult to confirm whether the decision-making of returning cases to 
routine recall would be the same when it has a direct immediate impact on clinical 
practice.  Subsequently only two studies (Mucci et al. 1999 and Ciatto et al. 2005) 
provide this information.  Mucci et al (1999) were establishing cost savings by 
arbitration and the authors acknowledged that non-blinded reading occurred and 
the second reader may therefore have been influenced by the first reader’s decision. 
Ciatto et al (2005) were also investigating the effectiveness of arbitration but did not 
use continuous cases, this was limited to periods when radiologists were available to 
perform a third read and follow-up data for 58% of the cases in which arbitration 
concluded a negative outcome were not available. Therefore, the effect of the 
arbitration process and subsequently cancer detection rates could only be estimated. 
Although CAD and Tomosynthesis were not a primary focus of this review, it was 
noteworthy that the evaluation of CAD as an arbiter although more sensitive than an 
independent 3rd reader, showed a statistically significant increase in normal cases 
being recalled to assessment with a relative increase of 10% (James and Cornford 
2009). Tomosynthesis studies (Skaane et al. 2013a, Skaane et al. 2013b and Lang et 
al. 2016) retrieved via this review also reported that there was a statistically 
significant difference in the overall number of women recalled as a result of 
arbitration in the cohort undergoing conventional FFDM + tomosynthesis versus 
FFDM alone.  Two studies (Cornford et al. 2005 and James and Cornford, 2009) 
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provide information that arbitration cases account for 20-22% of assessment cases in 
the UK (range 20-22%), which represents a significant proportion.  Therefore, 
although emergent technologies may improve the cancer detection rates, 
consideration needs to be given to the impact of extra cases requiring assessment.  
4.4.2 Consensus Studies 
Five papers (15,21,23,25,26) mentioned consensus as the method of resolving 
discordant cases with only two of the studies (Shaw et al. 2009 and Matcham et al 
2004) specifically looking at the effectiveness of the consensus process. The three 
remaining studies were evaluating CAD and tomosynthesis.  Therefore, limited data 
was available on recall rates to assessment following consensus with a range 31.1% 
(Skaane et al. 2007) to 65.6% reported (Matcham et al. 2004), and 68.9% - 34.4% of 
cases being returned to routine recall. The high number of cases returned to routine 
recall in the Norwegian study (Skaane et al. 2007) relates to the scoring system 
utilised where a score of 2 (defined as probably benign) or greater is referred for 
consensus discussion.  As per the arbitration studies, more women were allocated to 
consensus when mammograms were read with CAD (13.8% vs. 10.5%) to non-CAD 
reading (Khoo et al. 2005).   
4.4.3 Mixed Studies/Reviews 
Within eight of the nine mixed studies (3,11,12,14,16,17,19,20,22) it is not possible 
to differentiate the effect of arbitration versus consensus as the processes are either 
integrated in the discussion, or both are undertaken within the decision making 
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strategy i.e. mutual consensus between the two readers with persistent discordant 
case being reviewed by an arbitration panel. The Duijm et al (2004) study reports 
that this strategy resulted in 45% of cases being resolved by mutual discussion and 
55% still requiring arbitration by a panel, with 48.6% of the cases subsequently 
recalled.  The panel recalled if at least one arbitration member considered it 
necessary. However, there is no information provided on the agreement levels 
between the 3 panel arbitrators, this would therefore raise the question; would 
recall rates/detection rates have been different with a majority decision?  Recalling 
based on one member’s decision may have resulted in higher recall rates 
comparative to a majority decision and the subsequent effect on PPV remains 
unknown. 
Minimal pertinent information can be extracted from the (Posso et al. 2016) cost 
and health related outcome study (comparing single vs. double reading) other than 
discordant reading occurred in 4.5% of cases with 98.1% resolved by consensus and 
1.9% still requiring arbitration.  No interval cancer rates are provided and therefore 
results are not conclusive. Groenewoud et al (2007) although a paper primarily 
concerned with cost effectiveness of different reporting strategies stated that 
referral rates were highest with decision-making by consensus (73.8%) compared to 
arbitration (52.7%).  However, this was an experimental study with test cases and 
therefore not reflective of clinical practice. Published regional data was utilised to 
estimate the distribution of discrepant readings and there was an assumption that 
each referral of a case would lead to a diagnosis of cancer, which is not a 
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representative distribution within an assessment clinic.  Conversely, Blanks et al 
(1998) studied cancer detection rates for a variety of reading strategies and 
concluded that although consensus had a lower recall rate, the Standardised 
Detection Ratio (SDR) was higher for double reading with arbitration compared to 
double reading and consensus for both prevalent and incident screens.  Also, for 
incident screens the SDR for small (<15mm) invasive cancers was also higher (Double 
consensus =1.00 vs. Double arbitration =1.18).  This is noteworthy as the clinical 
perspective indicates a move to consensus over arbitration.    
Hukkinen et al (2006) was a small study involving 200 cases and although describing 
independent reading and conference consensus (the majority considered decisive) 
stated that they avoided readers discussing discordant cases to prevent the situation 
of one reader being overruled by another.  Consensus was calculated by average 
sensitivities and this achieved maximum results (75.4% sensitivity) when combining 
the readings of the four best performers.  This is similar in principle to the unique 
Collective Intelligence (CI) study (Wolf et al. 2015) that utilised a majority, quorum 
and weighted quorum rule tested against an individual radiologists performance.  In 
accordance with Hukkinen et al (2006) as group size increased all three CI rules 
achieved increases in true positives and decreases in false positives. Larger groups 
were declared to make more accurate decisions, but relatively small group sizes 
achieved performance improvements.  However, this was again a test set scenario 
with no influence on real-life cases.   
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A further variation in recall policy was discussed by Hofvind et al (2009) and 
Matcham et al (2004) who performed consensus on all recalls (concordant and 
discordant) resulting in 17.9% and 10.7% of the concordant readings to recall being 
over-ridden at consensus.  
4.4.4 Discordant Cancers 
Discordant cases that were subsequently histologically proven to be a cancer ranged 
from 2% (Caumo et al. 2011) to 23.6% (Hofvind et al. 2009), but with a very short (4 
month) study period the results of  Caumo et al (2011) need to be interpreted with 
caution. 
4.4.5 Follow-Up/False Negative Cases  
Regardless of the strategy used cancer cases were incorrectly dismissed to routine 
recall by both processes. Only twelve studies provided information regarding interval 
cancers; the length of follow-up was variable ranging from four months to seven 
years, and as a full screening interval (2 or 3years dependent upon country) was not 
complete prior to the reporting of some studies the true effect of cases returned to 
routine screening is unknown. Ciatto et al (2005) reported that 0.64% of dismissed 
arbitration cases were false negative but as discussed previously this is an 
incomplete data set with only 42% of cases followed up.  Shaw et al (2009) and 
Duijm et al (2004) report fairly low rates of cancer cases dismissed at consensus 1.1% 
and 3% respectively.  Interestingly, Jenkins et al (2014) showed 4.1% of false 
negative interval cancers were double reported as normal, which was significantly 
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lower compared to cases where at least one reader had indicated recall (10.9%; p< 
0.005). Following a review of consensus false–negative cases, Shaw et al (2009) 
report a change in practice recalling a much higher proportion of discordant cases 
when microcalcification is the mammographic abnormality. 
4.4.6 Tumour/Mammographic Characteristics Of Discrepant Cases. 
Klompenhouwer et al (2015a) described no difference in the proportion of DCIS, 
smaller tumours, lymph node involvement or advanced tumours between screen-
detected cancers and those missed at arbitration. Conversely Cornford et al (2005) 
indicate cancers detected following arbitration were smaller (p<0.045), a finding also 
supported by Cawson et al (2009). Lobular cancers which are often 
mammographically difficult to detect were reported to be more common in the 
arbitration group, albeit of borderline significance (Cornford et al. 2005: 1186).  The 
mammographic features were ‘more likely to present as parenchymal distortions 
(p<0.001), and less likely to be detected in fatty breasts (p<0.01)’. 
4.5 Chapter 4 Summary 
This chapter reported the synthesised data collected on arbitration and consensus 
processes.  It was found that there was a limited body of evidence relating to either 
processes and in particular a lack of prospective studies to determine their 
effectiveness in real-life clinical settings.  Methodological weaknesses were 
identified in some studies, and predominantly the lack of complete follow-up or 
reporting of true interval cancers compromises the ability to conclude the 
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effectiveness of the processes.  The following chapter reports the themes arising 
from the data synthesis, discusses the limitations of the review and proposes 






Chapter 5. Discussion 
The aim of this systematic scoping review was to establish what evidence there is to 
inform models of arbitration or consensus in mammography reporting, with a 
secondary aim of identifying gaps in the evidence base and recommendations for 
further research if required.  The scoping review has revealed a dearth of literature 
relating to process, in particular a lack of prospective studies demonstrating 
effectiveness of different processes in relation to outcomes (recall rates, cancer 
detection rate, PPV and programme sensitivity/specificity).  There is considerable 
variance in the processes used, a lack of guidance and a number of key areas where 
no evidence was retrieved.  This chapter discusses the details of the emergent 
themes. 
5.1 Lack of Guidelines 
The NHSBSP guidance (2011: 7) specifies that services unable to achieve the 
minimum standards for recall rates (prevalent and incident) must ‘carry out 
arbitration as a matter of routine’.  Review of the guidance revealed no information 
specifically relating to consensus.  This was also evident from the literature searching 
as no guidelines were identified on how to attain consensus if there is a discrepancy 
between the two readers.  The lack of guidance has resulted in breast unit’s 
implementing a variance in practice.  These differing work practices were not just 
evident across the UK but internationally, and therefore comparisons of outcomes 
are problematic.  
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5.2 Variations in Practice 
The scoping review revealed that there are inconsistences not only in which method 
is used to resolve the discordant cases, but also within the structure and scheduling 
of the processes. It is apparent from personal contact with experts that scheduling of 
arbitration or consensus in the UK ranges from ad-hoc impromptu arbitration to 
scheduled/timetabled consensus meetings.  The former reflects the practitioners 
experience and the lack of defined periods to review cases may not represent best 
practice. 
5.2.1 Different Definitions  
Definitions of consensus and arbitration are not clear-cut.  This was evident from the 
studies retrieved via the literature searches as well as from direct contact with 
clinicians.  The two terms are used interchangeably and often confusing with some 
studies reporting ‘arbitration by an individual’, others ‘arbitration by a panel’, and 
‘consensus based arbitration’ meetings. This confusion has also been experienced 
from the practitioner perspective at regional meetings where individuals debate 
whether the process they are utilising is technically classed as arbitration or 
consensus.  The literature review also highlighted a lack of consistent terminology 
regarding how the reading and arbitration strategy was undertaken.   Some utilised 
the term independent and others blinded to indicate that the second reader was 
unaware of the first reader’s decision; or the arbitrator was unaware of the reason 
for recall.  The lack of clear definitions makes it not only difficult to review the 
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literature and synthesise the findings, but it also adds to confusion in a clinical 
setting when discussing processes with no clear delineations. 
5.2.2 Different Approaches   
Within consensus and arbitration processes a range of approaches were used to 
reach the final decision.  Scenarios ranged from a 3rd independent reader who made 
the final decision to an independent review by a 3rd reader but with the majority 
opinion acted upon.  In other studies, cases were sent to arbitration only if the first 
readers could not achieve consensus; a panel (that may or may not incorporate the 
original reporters) then arbitrated persistent discordant cases.  The decision process 
for referring to assessment was also diverse ranging from a majority decision to 
acceptance if at least one member specified recall.  Inconsistencies were also 
evident in whether the arbitration was performed blinded, or whether the reason 
for the recall was made apparent and the role of arbitration was to decide on the 
action to be taken on an identified lesion.  The latter reflects the clinical practice 
experienced by the author. 
The literature review retrieved only one study (Hofvind et al 2009) that reported 
consensus of all recalls (concordant and discordant).  Contact with professional 
associates identified one unit with a previously high recall rate, which discussed all 
recalls at consensus meetings and frequently overrode the decision of both original 
film readers at the consensus review.  Conversely, some professionals also reported 
the scenario of sending all prevalent recalls (concordant and discordant) for 
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discussion at a consensus meeting.  The author’s clinical perception is that centres 
are moving to group consensus rather than a 3rd reader arbiter, but the number of 
units adopting this practice remains unknown at present.  This change in practice 
may relate to group consensus offering an opportunity for educational learning from 
cases, a perception that groups will miss fewer cancers or the fact that responsibility 
for decision-making should not lie with a particular individual.  It also raises the 
possibility that fear of litigation is an additional factor. 
5.2.3 Different Scoring / Classification 
A further area making international comparisons difficult was the disparity in scoring 
systems used to grade the mammographic images.  This was dependent upon the 
country of the study.  Differences in scoring systems may affect the perceived size of 
disparity and therefore which cases are sent to arbitration/consensus. In the 
Netherlands, studies utilised the Breast Imaging Reporting and Data System (BIRADS) 
produced by the American College of Radiologists (ACR), which works on a 0-6 scale.  
The Norwegian Breast Cancer Screening Program (NBCSP) utilised a unique system of 
scoring of 1-5.  This was essentially like the Australian (National Breast Cancer 
Centre) (Cawson et al. 2009) and Swedish (Lang et al. 2016) studies which report a 1-
5 category.   
The UK Royal College of Radiologists (RCR) Breast Group (RCRBG) system also works 
on a 1-5 scale but unlike the BIRADS categories does not provide a probability (%) of 
cancer and the short-term 6-month follow-up (category 3) is not utilised.  The 
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NHSBSP uses an IT system (National Breast Screening Service - NBSS), which equates 
to the RCRBG system, but assessment paperwork is documented with codes rather 
than numbers as demonstrated in Table 8 below.  




























































































4. S – 
Suspicious 











> 2% to ≤10% 
 
> 10% to ≤50% 
 
 












5. M - 
Malignant 



















Although Taylor et al. (2011) demonstrated that the UK RCR system could be 
transposed to the BIRADS system; the comparison of data with differing systems 
may serve to add confusion.  The Norwegian studies (Skaane et al. 2013a and 
Hofvind et al. 2009) describe a cumulative scoring process that determined which 
cases are sent to arbitration/consensus and subsequent management. An initial 
score of 2 or higher by either reader resulted in consensus, and a score of 3 or higher 
could not be returned to routine screening without agreement from the original 
reporter. Cases scoring 4 or 5 would not be dismissed.  
5.2.4 Different Recall Rates/Reporting Professional 
European guidelines recommend lower recall rates comparative to the UK 
programme and one of the strategies endorsed by Duijm et al. (2004) was the use of 
the highest reader recall.  This process requires that if any reader deems the 
mammogram abnormal, the case be automatically recalled for further assessment.  
However, this strategy is based on a remarkably low Dutch recall rate of 0.9% and 
would, therefore, have significant clinical implications in the UK setting with much 
higher recall rates.   
The literature revealed that in some countries, general radiologists were reporting 
mammography, as specialisation in screening is not mandatory.  Expert contact 
made during the review provided details from a 2015 American workshop (National 
Academies of Sciences, Engineering, and Medicine 2015).  This report summarised 
that in the USA some facilities have general radiologists reading all their 
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mammograms, others have radiologists who specialise in breast imaging, and hybrid 
situations exist where general radiologists perform the initial reading, with breast 
imaging specialists undertaking workups and biopsies.  This is disparate to UK 
practice where current quality standards include that all film readers (Radiologists 
and Radiographers) in the NHSBSP must complete a recognised course of study, have 
2 years’ regular film reading experience, read a minimum of 5,000 mammograms per 
year and participate annually in the Personal Performance in Mammographic 
Screening (PERFORMS™) reporting test.   
Overall, screening outcome is influenced by many interrelated factors and the 
disparities in screening interval; classifications, reading strategies and reader 
performance make comparisons problematic. 
5.3 Lack of Evidence  
From the literature reviewed it is apparent that the published data relating to 
arbitration and consensus is limited and great variability exists in how final decisions 
are made.  No research was found comparing the accuracy of an independent 3rd 
reader (arbitrator) versus consensus (group/panel review) of discordant cases.  
There was a supposition from some of the literature that fewer cancers will be 
missed by panel consensus compared to single reader arbitration.  However, no 
evidence was found to support this.  This is notable, as from a practitioner 
perception based on QA visits, and peer discussion I am very confident that the 
100 
 
majority of unit’s based in one large region have moved to consensus processes in 
favour of arbitration.  This view was also supported by e-mail correspondence from 
expert contact outside of the author’s local region.  The rationale for this change in 
practice is unclear. UK studies have elucidated that this might reflect the change in 
professional skill mix within the UK breast reporting system, but as many of the 
studies related to European countries where only radiologists would constitute 
consensus panels, there is a lack of evidence. 
The short time interval from reporting to review at consensus provides the 
opportunity for individuals to evaluate trends in personal missed/misdiagnosed 
cases.  Individuals are more likely to remember the circumstances and rationale for 
recalling/not recalling and hence the difference between a perception error and a 
decision-making error is evident. However, the dynamics within the consensus 
meetings can be a significant factor affecting the final decision as all individuals’ 
opinions should have an equal weighting and everyone must feel able to voice if they 
strongly disagree with the decision being made.   
No evidence was retrieved on how consensus meetings could be optimally 
structured. In particular, no studies were retrieved which examined the dynamics 
within breast consensus meetings and no research evaluated the complexities within 
a hierarchical structure undertaking decision making on discordant breast cases.  The 
collective intelligence study (Wolf et al. 2015) provided an interesting perspective as 
it removed the hierarchy and difficulties associated with group decision-making.  
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However, this model required multiple reads to evaluate a mammogram, and this 
may be problematic if units are struggling to achieve screen to results within a two-
week period.  
From a practitioner perspective, it is imperative that consensus meetings are 
scheduled to allow film readers to attend on a regular basis if they are to achieve 
improved performance.  However, the ultimate outcome post assessment or biopsy 
is the only way to confirm whether recall was justified and individuals will still need 
to audit their results.  Equally important may be that, if a particular Consultant 
(Radiologist or Radiographer) initially reports the case as normal; they will not be the 
best person to perform the work-up at assessment, as they either did not perceive 
the abnormality or may be predisposed to report a benign finding. 
Interestingly, the Blanks et al. (1998) study concluded that although consensus 
lowered the recall rate, the SDR was higher for double reading with arbitration for 
both prevalent and incident screens and smaller cancers (<15mm).  The audit 
undertaken by Jenkins et al. (2014) identified that no excess of interval cancers 
classified as uncertain or suspicious were returned to routine recall after arbitration.  
However, a significant message from this and the Hofvind et al. (2009) study was 
that the interval cancer rate was substantially higher in cases that had undergone 
arbitration or consensus relative to the rate among concordant negative screenings.  
Jenkins et al (2014) report that 19.4% of interval cancers categorised as uncertain 
and suspicious were not initially called by any reader compared to 36.1% that had 
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been recalled by at least one film reader (p < 0.001). This raises the question of 
whether arbitration or consensus could be refined to aid earlier detection in such 
cases.   
Although studies have investigated the fatigue associated with screen reading, no 
studies were found which evaluated the impact of performing arbitration or 
consensus at a particular time of day, the day of the week, the duration of consensus 
meetings, or the impact of the immediate prior task on decision making. 
The scoping review emphasised that a number of the studies (five) utilised test cases.  
Although this provides a means of evaluating a reasonable number of discrepant 
cancer cases in a short period, readers will always be aware of the test situation and 
that test sets will be loaded with a higher proportion of cancers to normal cases 
which may affect performance levels.  The immediate feedback provided by test sets 
serves as a valuable learning process however; the correlation of performance with 
real-life clinical outcomes remains an area for further research. 
Overall, either the short follow-up period, lack of complete data, absence of 
reporting of true interval cancers versus false negatives and the retrospective nature 
of many studies means there is insufficient evidence to assess the effectiveness of 




5.4 Emerging Technologies  
Several studies included an assessment of CAD or DBT.  Although an evaluation of 
these was beyond the scope of the review it was notable that both technologies 
impacted on the number of arbitration cases and subsequent recalls.   
The 2013(b) Skaane et al. study demonstrated that although 62% of radiologists 
referred fewer patients for arbitration with the use of FFDM and tomosynthesis the 
overall number of women recalled after arbitration was larger for this cohort (351 
versus 265), which was also supported by Lang et al. (2016) and Skaane et al. (2013a).  
The authors hypothesised that the higher recall rate was a result of reader bias in 
favour of mammography at the arbitration meetings, which may reduce as the 
confidence in a new procedure develops.  A systematic review retrieved in the final 
search in Scopus (4th June 2016) concludes that, compared to FFDM alone, DBT with 
FFDM increases invasive cancer detection rates and may reduce false negative 
recalls (Hodgson et al. 2016).  An exception within the studies reviewed was the 
Norwegian OTST study that reported higher recall and false-positive rates after 
arbitration for DBT and FFDM, but potential biases were acknowledged that might 
explain this. 
An important factor related to the use of these new technologies is that they may 
detect more cancers and hence produce more recalls.  Therefore, the role of 
arbitration and consensus will be paramount in reducing false positives, as resources 
within assessment clinics are already limited in some services.  Klompenhouwer et al 
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(2015a: 2828) recently suggested that CAD might be utilised as an arbitrator when 
‘no other method of consensus or arbitration is available’.  Within this review, the 
CAD studies identified were primarily concerned with aiding detection of lesions 
rather than assisting the decision making process.  The James and Cornford (2009) 
study was unique in investigating the potential of CAD as an arbitrator, but this study 
as with others indicated that CAD produced too many false prompts.  However, 
these studies were undertaken in 2009 or earlier, and CAD systems may well have 
evolved so that scales of suspicion could be of practical clinical use.   
As DBT is showing increased cancer detection rates across all breast densities, if 
implemented at the screening stage this may represent the opportunity to assess 
whether second reading of the BIRADS category one cohort (almost entirely fat, 
glandular tissue is less than 25%) is justified.  Single reading would be an entirely 
new concept to many readers within the current workforce and assurance of quality 
performance would be a pre-requisite.  
5.5 Cost Analyses 
Economic analyses were not the main focus of this review.  However, some retained 
papers were primarily concerned with the cost of differing reporting strategies.  
5.5.1 Length of Read 
Reading times in the CAD cost analysis (Khoo et al., 2005) were assumed to be a 
mean 25 seconds per case for the initial report, plus arbitration was assigned 2.2 
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minutes of a radiologist’s time.  Essentially arbitration is the 3rd read and therefore 
should not take a disproportionate amount of time to report. However, the 
difference above acknowledges that consensus discussion is likely to take longer.  
Any future cost analysis comparing these two strategies would need to determine 
accurate resource use (personnel grade and time). 
5.5.2 Impact of Changes In Practice 
The costings reported in the Mucci et al (1999) study related to FNA.  NCB or 
Vacuum-Assisted Biopsy (VAB), which is more expensive, has largely replaced this 
and therefore the Mucci et al (1999) study is not comparable to current UK practice.  
Methodological weaknesses were also identified in the Groenewoud et al (2007) 
study which was undertaken in an experimental setting and therefore not reflective 
of daily practice, with an assumption that all cases recalled would be cancer.  This is 
disproportionate to a real-life assessment clinic.   
The overall cost of assessment is multifaceted.  It depends on the number of cases 
initially recalled and the proportion that are subsequently positive. A high recall rate 
would indicate that a greater percentage of cases would be negative or benign.  As 
discussed in chapter 2, during the assessment, the workup of cases can follow many 
pathways.  The resources (staff time and consumables) required for these may be 
vastly different.  It is, therefore, complicated to cost an assessment episode 
(particularly false-positives with an unknown work-up variable).  Given the current 
workforce shortages the use of a 3rd reader arbiter versus a consensus meeting 
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involving a group of individuals is an important consideration in terms of available 
skills as well as costs. Costs are usually equal in terms of additional imaging.  But, 
depending on how departments run; there is the potential for breast care nursing 
and administrative costs to vary between assessment clinics.   
The most recent study of costs and health-related outcomes (Posso et al 2016), 
evaluated double versus single reading of mammograms. From a UK perspective the 
costings are not directly transferable as an FNAC is costed as more expensive 
(€141.8) than a biopsy (€131.7).  The converse is true in UK practice and as 
previously discussed; NCB is the recommended sampling method. The authors 
acknowledge that the study was performed without information about interval 
cancers hence the results are not conclusive.  A cost-effectiveness evaluation would 
be required to confirm ‘Whether double reading is still necessary at digital screening 
mammography’ (Posso et al 2016: 10). From the limited studies included in this 
scoping review, no conclusions can be drawn regarding cost effectiveness. 
However, a consequence of double reporting is the associated delay in delivery of 
screening results.  Individual units will differ in the delay before the 2nd read is 
performed. It can be difficult if there is a shortage of film readers or the 
infrastructure does not provide backfill-reporting sessions during periods of annual 
leave (the delay could be days) putting pressure on services to achieve the screen to 
assessment target (within three weeks). Although the strategy employed by Skaane 
et al (2013b) may represent low thresholds for arbitration, it does raise the question 
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of whether there is value in second reading cases classified as a 5 (malignant) by the 
first reader.  It could be that the 2nd reader may detect further foci of disease or 
contralateral areas of concern, but as the person leading the assessment is obliged 
to review the case as a whole this provides the opportunity for review and workup of 
any further areas of concern considered necessary. A single read of these cases may 
represent efficiency savings in resources and reduce patient anxiety as a recall to 
assessment could be instigated earlier.  It may be useful to establish, in cases 
classified as malignant by the 1st reader, what the pick-up rate of further disease is 
by having a 2nd read.  It is uncertain how many cases in the cohort graded as 
suspicious (4) or malignant (5) by one reader are overridden at arbitration or 
consensus; or whether all cases lie within the uncertain (or BIRADS 0) category.  This 
cohort has been shown to have a low PPV at recall and, if prevalent recall rates are 
high in some units, this may be the category that requires rigorous scrutiny and 
evaluation of whether cases are being over recalled.  This may also be the category 
that benefits from review of concordant as well as discordant recalls as the level of 




5.6 Discussion of Method and Limitations 
5.6.1 Methods 
The strength of this scoping review is the systematic approach adopted and the 
range of evidence that was identified to provide a comprehensive overview of the 
‘volume, nature, and characteristics of primary research’ in the pre-specified areas 
(Arksey and O’Malley, 2005: 6). Seven databases were searched, some with multiple 
searches strategies to incorporate arbitration and consensus processes.  A large 
volume of abstracts was reviewed (601), with 43 full text papers examined.  
Although only 26 studies met the final inclusion criteria this reflects the lack of 
evidence within this field. 
With a short time frame consideration had to be given to what was practically 
achievable.  Therefore, the scope was limited to the processes while endeavouring 
to ensure that the ability to answer the research question was not compromised.  
Use of two reviewers helped to guard against bias in application of inclusion and 
exclusion criteria, and search strategies to aid reproducibility.  However, it is 
recognised that a single reviewer performed extraction and synthesis of pertinent 
data.  These stages therefore, remain subjective and it is possible that different 
interpretations of the same set of studies might occur if undertaken by another 
individual.  Nevertheless, a clinician undertook the data extraction and therefore the 
complexities of the clinical components of a study may be better interpreted.  
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Efforts were made to undertake a comprehensive review.  For the search strategy to 
identify a manageable number of papers, the scope of the review was limited to the 
effectiveness of the processes, exclusive of cost.  Although the search terms selected 
were wide-ranging, other terms may have identified further articles.  It is also 
possible that not all studies in the published or grey literature were sourced.  
Searches were not designed to incorporate a comparison of single reading versus 
double reading. Attributes of the personnel undertaking arbitration was also 
considered beyond the scope of the review and therefore no conclusions can be 
drawn on how an individual’s experience, decision-making skills, audit or reflective 
learning, affect the processes. 
5.6.2 Limitations 
The QUADAS tool was developed as a means of assessing the quality of diagnostic 
accuracy studies incorporated into systematic reviews, (Whiting et al 2003a); but 
results may be biased if aggregated data have not been individually evaluated for 
quality.  Whiting, Harbord and Kleijnen (2005b) also identify that a major problem in 
quality scoring is the lack of objectivity in defining the weighting criteria.  As 
different models utilise varying principles and weightings, combined scores can be 
diverse with no indication of which represents maximum dependability. Whiting, 
Harbord and Kleijnen (2005:7) conclude, ‘Quality scores should not be incorporated 
into diagnostic systematic reviews’.  In 2016 Whiting et al (2016c) reported, ‘A new 
tool to assess the risk of bias in systematic reviews’ (ROBIS) as ‘flaws or limitations in 
the design or conduct of a review have the potential to bias results’ (Whiting et al 
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2016c: 226)  
Although quality assessment is not usually undertaken in scoping reviews, it was 
considered that critical appraisal of included studies could help identify any flaws 
that might bias the findings of the report as a whole.  To make quality assessment 
feasible, critical appraisal was limited to whether diagnostic studies met the CASP 
criteria, but there was no scoring or ranking assigned.  
Because searches were limited to articles published in English this may have 
excluded some relevant studies. As the initial searches were undertaken less than 
five months ago, it was not deemed necessary to re-run these on all databases.  The 
database (Scopus) that had retrieved the greatest number of relevant papers was 
selected and searches re-run on the 4th June 2016.  It is acknowledged that this 
strategy may not have retrieved all recent papers.   
A decision was made to include the Ciatto et al. (2005) study although 
methodological weaknesses were identified as incomplete data was reported.  As it 
represents one of the few prospective studies primarily reporting the effectiveness 
of arbitration, it was considered important to retain.  Study authors could have been 
contacted to request more information, but as the research was undertaken in 2005 
it was decided that if a full data set was available a further study would have been 
published.  Nevertheless, the judgement to record the strengths and weaknesses of 
studies in the data extraction table provided an indication of the robustness and 
limitations of the results.  
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Because of the time constraints, working practices could only be described from a 
few specific professional contacts.  It was beyond the scope of this study to gain a 
national perspective.  Further evidence from a larger and wider ranging number of 
centres within the UK could have identified a wider range of strategies. 
5.7 Conclusions 
The scoping review presented in this thesis has explored the available evidence on 
models of arbitration or consensus in mammography reporting.  A limited number of 
studies were identified which have assessed the effectiveness of either strategy and, 
within these; there was heterogeneity in study design, definitions and outcomes.  
The review has identified a lack of guidance and underpinning evidence to inform 
how best to use arbitration or consensus to resolve discordant reads, and that no 
current system correctly recalls all discordant cancer cases.  
The purpose of the review was not to criticise the methods that breast units have 
employed to resolve discordant reports but to provide an understanding of the 
processes that are used.  The evidence shows that breast units have developed 
differing strategies for managing discordant reads and that the rationale for these is 
unclear.  Consensus approaches encompass a diverse range of scenarios and it was 
not possible to establish the influence of component factors on decision-making.  
In accordance with a scoping review’s descriptive nature no attempt has been made 
to synthesise evidence on outcomes for these processes.  The impact that the 
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arbitration or consensus process might have on breast unit’s resources, the ability to 
maintain reporting standards, subsequent potential delays in patient pathways and 
cost effectiveness have not been explored. 
No review of a comparable nature has been identified making this a novel study.  
Although the findings do not provide conclusive evidence on the effectiveness of 
different arbitration or consensus processes, they are valuable in providing a 
foundation upon which to build further knowledge (Pawson 2013). 
5.8 Future Research or Recommendations 
The scoping review has described the complexities within mammography reporting 
and that the UK is unique in that a consensus meeting may include a range of 
professionals (Radiologists, Advanced practitioners and Consultant radiographers).  
Concerns about the future availability of specialist breast radiologists have been 
highlighted (RCR 2016) and some services may already have or imminently have a 
single breast-screening radiologist.  With the predicted retirement of the most 
experienced radiologists, units may soon have a workforce where advanced and 
consultant practitioners possess a substantial knowledge base relative to a newly 
appointed radiologist. 
As the NHSBSP guidance on arbitration personnel is currently under review, it 
presents an opportune time to consider the qualities and characteristics required by 
an individual to undertake decision-making effectually.  Under current NHSBSP 
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guidance a consultant radiographer can lead an assessment clinic directing 
additional imaging, performing appropriate interventions or ultimately discharging 
the lady to routine screening.  The autonomous nature of the role extends to MDT 
meetings where advice can be given on patient management, but based on current 
clinical protocols arbitration of discrepant screen readings is considered a medic 
responsibility. Interestingly, a recent survey (Culpan 2016: 4) establishing the 
participation of UK radiographers in mammography image interpretation reports 
that 23% (15/66) of radiographers stated ‘giving a third opinion or casting vote in 
discordant double reading’ of screening.  This implies that units have already 
implemented changes in local practice through governance systems prior to the 
review of the guidance.   
The primary aim of future research would be to establish current practice. For 
example, what do practitioners understand by the terms consensus and arbitration? 
and to develop clear precise definitions and guidance on the processes.  A review of 
actual clinical practice could be ascertained via a national survey to establish a 
number of factors.  What strategies are centres currently using for prevalent and 
incident screens, what professionals constitute consensus meetings, are specific 
times/days scheduled for arbitration or consensus, and which cases are reviewed 
(concordant and/or discordant only).   
Further research would be required to: 
1. Explore and explain how and why a system was established.   
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2. Explore the impact on the professionals of ad-hoc impromptu 
arbitration/consensus meetings and the effects on managing a service with 
such variable scheduling.  Are individuals under pressure to make impromptu 
decisions as cases are about to breach targets? Is there an impact on the 
professional’s performance relative to fatigue, time of day, immediate prior 
task? 
3. Explore the clinical implications (time/resources/benefits) of a consensus 
panel reviewing all recall cases (concordant and discordant).  Does the time 
and resources invested in reviewing concordant recalls result in significant 
reductions in recall rates? 
4. Explore the dynamics of the professionals that constitute consensus meetings 
- Do the dynamics change relative to the individuals present i.e. grade and 
experience of the staff?  Determine how the final decision is made – is this a 
majority decision, weighted by experience, or by profession? 
5. Third person arbitration or consensus lead is traditionally a medic 
responsibility.  Given the current NHSBSP arbitration guidance review, if 
delegation to non-medics is recommended, further research may be required 
to ascertain why some sites will be early adopters and some sites possibly 
non-adopters of the guidance. Would this relate to varying professional 
principles across organisations and more notably to determine the 
consequences of disparate practice not just for professionals, but service 
users?   In particular, to determine the impact on outcomes of performance 
measures (recall rates, PPV, screen to routine recall and screen to 
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assessment).  Would radiographer arbitration result in an increase in recall 
rates as seen in the NDROR trial, albeit it was considered insignificant? It will 
also be important to evaluate the impact on the individuals of undertaking 
this task. Although it is likely to be the Director of Breast Screening unit’s 
responsibility to delegate to competent individuals, do radiographers 
consider they are confident/experienced enough to take on the 
responsibility? Would they only favour leading a consensus group rather than 
undertaking an independent 3rd read?  Would any radiographers decline the 
delegation?  Or would they embrace the change. 
A distinctive approach to further research would be to prospectively explore the 
Collective Intelligence theory proposed by Wolf et al (2015) which removes the 
documented problems associated with group-think, and aims to deliver improved 
performance over a solitary experienced arbitrator.  However, it is recognised that 
this method requires multiple readers and may be hindered by the current and 
future workforce shortages.  Does the future of breast screening reporting lie in a 
revolution of CAD systems set with varying thresholds to perform the initial 
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Appendix A. NHSBSP Quality Standards 
Objective  Criteria Minimum standard Achievable standard 
1. To maximise the 
number of eligible 
women who attend for 
screening 
The percentage of 
eligible women who 
attend for screening  
 
>70% of invited 
women to attend for 
screening 
80% 
2. To maximise the 
number of cancers 
detected 
 
a) The rate of invasive 
cancers detected in 
eligible women invited 
and screened  
 
b) The rate of cancers 





detection ratio (SDR) 
Prevalent screen >3.6 
per 1,000  
Incident screen >4.1 
per 1,000  
 
Prevalent screen >0.5 
per 1,000  
Incident screen >0.6 
per 1,000 
 
 > 1.0 
 
 
Prevalent screen >5.1 
per 1,000  







3. To maximise the 
number of small invasive 
cancers detected 
 
The rate of invasive 
cancers less than 15 mm 
in diameter detected in 
eligible women invited 
and screened 
 
Prevalent screen >2.0 
per 1,000 
 
Incident screen > 2.3 
per 1,000 
 
Prevalent screen >2.8 
per 1,000  
 
Incident screen >3.1 
per 1,000 
 
4. To achieve optimum 
image quality 
 
a) High contrast spatial 
resolution b) Minimal 
detectable contrast 5-6 
mm detail 0.5 mm detail 
0.25 mm detail c) 
Optical density 
 
>12 lp/mm  
 
< 1.2%  






< 3%  
<5% 
 
5. To limit radiation dose Mean glandular dose 
per exposure for a 
standard breast at 
clinical settings 
 
<2.5 mGy  
6. To minimise the 




The number of repeat 
examinations  
 
<3% of total 
examinations 
<2% of total 
examinations 
7. To minimise the 
number of women 
screened who are 
referred for further tests 
 
a) The percentage of 
women who are 
referred for assessment  
 
b) The percentage of 
women screened who 





Incident screen <7% 
 
<0.25% 
Prevalent screen <7% 




8. To ensure that the 
majority of cancers, both 
palpable and impalpable, 
receive a non-operative 
tissue diagnosis of cancer 
 
(a) The percentage of 
women who have a non-
operative diagnosis of 
cancer by cytology or 
needle histology after a 
maximum of two visits  
 
(b) The percentage of 
women who have a non-
operative diagnosis of 
DCIS by cytology or 
needle histology after a 
















9. To minimise the 
number of unnecessary 
operative procedures 
 
The rate of benign 
biopsies 
 
Prevalent screen <1.5 
per 1,000 
 
Incident screen <1.0 
per 1,000 
Prevalent screen <1.0 
per 1,000 
Incident screen <0.75 
per 1,000 
10.To minimise the 
number of cancers 
presenting between 
screening episodes in the 
women screened 
The rate of cancers 
presenting in screened 
women  
a) in the two years 
following a normal 
screening episode 
 b) in the third year 
following a normal 
screening episode 
 
Expected standard 1.2 per 1,000 women 
screened in the first two years 1.4 per 1,000 
women screened in the third year 
 
11.To ensure that 
women are recalled for 
screening at appropriate 
intervals 
 
The percentage of 
eligible women whose 
first offered 
appointment is within 







12.To minimise anxiety 
for women who are 
awaiting the results of 
screening 
 
The percentage of 
women who are sent 







13.To minimise the 




The percentage of 
women who attend an 
assessment centre 
within three weeks of 








diagnostic delay for 
women who are 
diagnosed non-
operatively 
Proportion of women 
for whom the time 
interval between non-
operative biopsy and 










15.To minimise the delay 
for women who require 
surgical assessment 
 
Proportion of women 
for whom the time 
interval between the 
decision to refer to a 
surgeon and surgical 







16.To minimise the delay 
between referral for 
investigation and first 
breast cancer treatment 
 
The percentage of 
women who are 
admitted for treatment 
within two months of 








Appendix B. Initial Keywords and Subject Headings  
Criteria Where to search Keywords  
>5000 films per year 














Cochrane Database of Systematic 
Reviews. 
Web of science 
Popline 
Grey literature will also be searched: 
conference proceedings, theses 
dissertations’, book citations, websites of 
NHS England, NHS Breast Cancer 
Screening Programme; Professional body 
publications/guidance, HEE, NCIN, 
NHSBSP cancer screening.  Searches will 








Diagnostic errors/*prevention & control/*trends 




Early detection of cancers/*methods 
False negative reactions 













Pattern Recognition, Visual 
Perception 









Sensitivity and specificity 
Task Performance and Analysis 
Volume 
Vigilance decrement 
> 2yrs film reading 
experience in breast 
screening. New Radiologist 
- Full appropriate training, 
ideally undertaken a breast 
fellowship 













Reproducibility of Results 
Task Performance and Analysis 
Training* 
Full participation in 








Clinical practice guidelines 
Clinical Protocols 
Clinical strategies 









Pattern Recognition, Visual 





MDT. Desirable > 20 per 
year 
 Breast Neoplasms/*radiography 
Clinical Protocols 
Health care team 
Hospital /hospital setting/hospital based  
Integrated care 
Interdisciplinary/team 
Medical care team 
Multidisciplinary  
Multidisciplinary team 
Peer review measures 
Patient care team 
Person-centred care, 
Secondary care 
Regular audit personal and 
team results, Reflective 
learning 

















Task Performance and Analysis 
Review of interval cancers, 
screen detected cancers 




Breast Neoplasms/*diagnosis  
Cancer detection rates 
*Clinical Competence 
Diagnostic Errors/*prevention & control/*statistics 
& numerical data 
Diagnostic Imaging/*statistics & numerical data 
Diagnostic Errors/*prevention & control/*trends 






MEDLINE/*statistics & numerical data 
Missed cancers 
Neoplasms/*radiography/*diagnosis/*pathology 






Predictive Value of Tests 
Prognosis 
Program evaluation 
Quality indicators, Health care* 
Quality Improvement/*statistics & numerical data 
Radiology/*education/*statistics & numerical data 
Radiological review 
Reproducibility of Results 
Retrospective Studies 





development and appraisal, 
SCoR 4 pillars of consultant 
radiographer practice 
 Advanced Practice/Radiography* 




Continued Professional Development 
Continuing Medical Education 
Education, Distance/organisation & administration 
Education medical 
Health professional education  
Health services research/methods 
Humans 
Practicing health professionals  
Health professional students  
Mammography 
Models, Educational 
Universities/organization & administration 
Organisational innovation 
Physician–radiographer relations 











Appendix C. Pubmed Search 
 
  
Recent queries in Pubmed 
 Search Query Items found 
#1 
Search ("breast neoplasm" or 
"breast carcinoma" or "breast 
tumour' or "breast tumor" or 
"breast cancer") 8796 
#2 
 
Search ("mass screening" or 
"breast scan"or "breast screen" or 
" breast radiograph" or "breast 
imaging" or "breast visualise" or 
"breast test" or "breast 
mammogram" or "breast 
diagnosis") 90602 
#3 
Search ("mammogram" or 
"mammography" or) 31899 
#4 Search (#2 or #3) 113648 
#5 
Search ("early detection of cancer" 
or "National health service breast 
screening program" or "NHSBSP" 
or "UK breast screening program" 
or "NHS breast screening 
program") 12665 
#6 Search (#1 and #4 and #5) 12 
#7 
Search ("arbitration" or 
"negotiation" or "discordance" or 
"discrepancy" or "disparity" or 
"disagree" or "conflict" or 
"different" or " inconsistent" or 
"variation" or " consensus" or 
"uncertain") 2994590 
#8 Search (#6 and #7) 5 
140 
 
Appendix D. Medline Arbitration Search 
1. Medline; exp BREAST NEOPLASMS/; 233023 results 
2. Medline; (breast adj3 (neoplasm* OR carcinoma* OR tumour* OR tumor* OR 
cancer*)).ti,ab; 238107results 
3. Medline; 1 OR 2; 296042 results 
4. Medline; exp MASS SCREENING/; 105328 results 
5. Medline; (breast adj3 (scan* OR screen* OR radiograph* OR imaging OR visualise 
OR visualize OR 
exam* OR test* OR mammogra* OR routine* OR check* OR diagnos* OR 
detect*)).ti,ab; 49354 results 
6. Medline; (mammogra* adj3 (scan* OR screen* OR visualise OR visualize OR exam* 
OR test* OR 
breast*)).ti,ab; 14103 results 
7. Medline; exp MAMMOGRAPHY/; 25226 results 
8. Medline; 4 OR 5 OR 6 OR 7; 159997 results 
9. Medline; "Early detection of cancer*".ti,ab; 953 results 
10. Medline; ("National Health Service Breast Screening Program" OR 
"NHSBSP").ti,ab; 86 results 
11. Medline; "UK breast screen* program*".ti,ab; 35 results 
12. Medline; "NHS breast screen* program*".ti,ab; 107 results 
13. Medline; 9 OR 10 OR 11 OR 12; 1150 results 
14. Medline; 3 AND 8 AND 13; 287 results 
15. Medline; exp NEGOTIATING/; 5256 results 
16. Medline; (arbitration* OR arbitrat* OR discordan* OR discrepan* OR disparity* 
OR negotiat* OR 
disagree* OR conflict* OR differen* OR inconsisten* OR variation* OR consensus* 
OR uncertain*).ti,ab; 
5001928 results 
17. Medline; 15 OR 16; 5004649 results 
18. Medline; 14 AND 17; 96 results 
19. Medline; 18 [Limit to: (Language English) and Humans]; 84 results 
141 
 




Appendix F. EMBASE Arbitration Search 
Search History:  
1. EMBASE; exp BREAST CANCER/; 327328 results.  
2. EMBASE; exp BREAST TUMOR/; 395504 results.  
3. EMBASE; (breast adj3 (neoplasm* OR carcinoma* OR tumour* OR tumor* OR 
cancer*)).ti,ab; 320225 results.  
4. EMBASE; 1 OR 2 OR 3; 437065 results.  
5. EMBASE; exp MASS SCREENING/; 176405 results.  
6. EMBASE; (breast adj3 (scan* OR screen* OR radiograph* OR imaging OR visualise 
OR visualize OR exam* OR test* OR mammogra* OR routine* OR check* OR 
diagnos* OR detect*)).ti,ab; 55378 results.  
7. EMBASE; (mammogra* adj3 (scan* OR screen* OR visualise OR visualize OR 
exam* OR test* OR breast*)).ti,ab; 15742 results.  
8. EMBASE; exp DIGITAL MAMMOGRAPHY/ OR exp MAMMOGRAPHY/; 44056 results.  
9. EMBASE; 5 OR 6 OR 7 OR 8; 241733 results.  
10. EMBASE; "Early detection of cancer*".ti,ab; 1295 results.  
11. EMBASE; ("National Health Service Breast Screening Program" OR 
"NHSBSP").ti,ab; 159 results.  
12. EMBASE; "UK breast screen* program*".ti,ab; 51 results.  
13. EMBASE; "NHS breast screen* program*".ti,ab; 158 results.  
14. EMBASE; 10 OR 11 OR 12 OR 13; 1617 results.  
15. EMBASE; 4 AND 9 AND 14; 443 results.  
16. EMBASE; exp INTERPERSONAL COMMUNICATION/; 450801 results.  
17. EMBASE; (arbitration* OR arbitrat* OR discordan* OR discrepan* OR disparity* 
OR negotiat* OR disagree* OR conflict* OR differen* OR inconsisten* OR variation* 
OR consensus* OR uncertain*).ti,ab; 6118002 results.  
18. EMBASE; 16 OR 17; 6434718 results.  
19. EMBASE; 15 AND 18; 162 results.  
20. EMBASE; 19 [Limit to: Human and (Languages English)]; 142 results.  
21. EMBASE; 20 [Limit to: Human and (Languages English) and Publication Year 2005-
2016]; 101 results.  
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Appendix G. EMBASE Decision Making Search 
Search history: 
1. EMBASE; exp BREAST CANCER/; 325856 results 
2. EMBASE; exp BREAST TUMOR/; 393803 results 
3. EMBASE; (breast adj3 (neoplasm* OR carcinoma* OR tumour* OR tumor* OR 
cancer*)).ti,ab; 318694 results 
4. EMBASE; 1 OR 2 OR 3; 435037 results 
5. EMBASE; exp MASS SCREENING/; 175689 results 
6. EMBASE; (breast adj3 (scan* OR screen* OR radiograph* OR imaging OR visualise 
OR visualize OR exam* OR test* OR mammogra* OR routine* OR check* OR 
diagnos* OR detect*)).ti,ab; 55141 results 
7. EMBASE; (mammogra* adj3 (scan* OR screen* OR visualise OR visualize OR 
exam* OR test* OR breast*)).ti,ab; 15697 results 
8. EMBASE; exp DIGITAL MAMMOGRAPHY/ OR exp MAMMOGRAPHY/; 43936 results 
9. EMBASE; 5 OR 6 OR 7 OR 8; 240771 results 
10. EMBASE; "Early detection of cancer*".ti,ab; 1290 results 
11. EMBASE; ("National Health Service Breast Screening Program" OR 
"NHSBSP").ti,ab; 158 results 
12. EMBASE; "UK breast screen* program*".ti,ab; 49 results 
13. EMBASE; "NHS breast screen* program*".ti,ab; 158 results 
14. EMBASE; 10 OR 11 OR 12 OR 13; 1609 results 
15. EMBASE; 4 AND 9 AND 14; 443 results 
16. EMBASE; exp DECISION MAKING/; 241331 results 
17. EMBASE; ("decision mak* OR shared decision making" OR "medical decision 
making" OR "choice behaviour" OR "problem solving" OR "clinical decision analysis" 
OR "critical think*" OR "decision aids" OR "Task performance and analysis").ti,ab; 
23459 results 
18. EMBASE; 16 OR 17; 259939 results 
19. EMBASE; 15 AND 18; 7 results 







Appendix H. CINAHL Search 
Search Historybrary.nhs.uk 
￼1. CINAHL; exp BREAST NEOPLASMS/ OR exp CARCINOMA, LOBULAR/; 38776 
results. 
2. CINAHL; (breast adj3 (neoplasm* OR carcinoma* OR tumour* OR tumor* OR 
cancer*)).ti,ab; 29790 results. 
3. CINAHL; 1 OR 2; 43220 results. 
4. CINAHL; exp HEALTH SCREENING/; 46351 results. 
5. CINAHL; (breast adj3 (scan* OR screen* OR radiograph* OR imaging OR visualise 
OR visualize OR exam* OR test* OR mammogra* OR routine* OR check* OR 
diagnos* OR detect*)).ti,ab; 8223 results. 
6. CINAHL; (mammogra* adj3 (scan* OR screen* OR visualise OR visualize OR exam* 
OR test* OR breast*)).ti,ab; 2778 results. 
7. CINAHL; exp MAMMOGRAPHY/ OR exp RESCREENING/ OR exp BREAST/; 8128 
results. 
8. CINAHL; 4 OR 5 OR 6 OR 7; 56692 results. 
9. CINAHL; "Early detection of cancer*".ti,ab; 121 results. 
10. CINAHL; ("National Health Service Breast Screening Program" OR 
"NHSBSP").ti,ab; 15 results. 
11. CINAHL; "UK breast screen* program*".ti,ab; 8 results. 
12. CINAHL; "NHS breast screen* program*".ti,ab; 44 results. 
13. CINAHL; 9 OR 10 OR 11 OR 12; 182 results. 
14. CINAHL; 3 AND 8 AND 13; 81 results. 
15. CINAHL; exp ARBITRATION/; 252 results. 
16. CINAHL; (arbitration* OR arbitrat* OR discordan* OR discrepan* OR disparity* 
OR negotiat* OR disagree* OR conflict* OR differen* OR inconsisten* OR variation* 
OR consensus* OR uncertain*).ti,ab; 370113 results. 
17. CINAHL; 15 OR 16; 370244 results. 
18. CINAHL; 14 AND 17; 15 results. 
19. CINAHL; 18 [Limit to: (Language English)]; 14 results. 
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Appendix I. Cochrane Decision Making Search 
Last Saved: 19/01/2016 16:14:17.733 
Description:   
ID Search  
#1 MeSH descriptor: [Breast Neoplasms] explode all trees 
#2 breast adj3 (neoplasm* or carcinoma* or tumour* or tumor* or cancer*)  
#3 #1 or #2  
#4 MeSH descriptor: [Mass Screening] explode all trees 
#5 breast adj3 (scan* or screen* or radiograph* or imaging or visualise or 
visualize or exam* or test* or mammogra* or routine* or check* or diagnos* or 
detect*)  
#6 mammogra* adj3 (scan* or screen* or visualise or visualize or exam* or test* 
or breast*)  
#7 MeSH descriptor: [Mammography] explode all trees 
#8 #4 or #5 or #6 or #7  
#9 "Early detection of cancer*"  
#10 "National Health Service Breast Screening Program" or "NHSBSP"  
#11 "UK breast screen* program*"  
#12 "NHS breast screen* program*"  
#13 #9 or #10 or #11 or #12  
#14 #3 and #8 and #13  
#15 MeSH descriptor: [Decision Making] explode all trees 
#16 MeSH descriptor: [Decision Support Techniques] explode all trees 
#17 "decision mak* OR shared decision making" or "medical decision making" or 
"choice behaviour" or "problem solving" or "clinical decision analysis" or "critical 
think*" or "decision aids" or "Task performance and analysis"  
#18 #15 or #16 or #17  




Appendix J.  Cochrane Arbitration Search 
Last Saved: 18/01/2016 19:02:17.644 
Description: 
ID Search 
#1 MeSH descriptor: [Breast Neoplasms] explode all trees 
#2 breast adj3 (neoplasm* or carcinoma* or tumour* or tumor* or cancer*) 
#3 #1 or #2 
#4 MeSH descriptor: [Mass Screening] explode all trees 
#5 breast adj3 (scan* or screen* or radiograph* or imaging or visualise or visualize 
or exam* or test* or mammogra* or routine* or check* or diagnos* or detect*) 
#6 mammogra* adj3 (scan* or screen* or visualise or visualize or exam* or test* or 
breast*) 
#7 MeSH descriptor: [Mammography] explode all trees 
#8 #4 or #5 or #6 or #7 
#9 "Early detection of cancer*" 
#10 "National Health Service Breast Screening Program" or "NHSBSP" 
#11 "UK breast screen* program*" 
#12 "NHS breast screen* program*" 
#13 #9 or #10 or #11 or #12 
#14 #3 and #8 and #13 
#15 MeSH descriptor: [Negotiating] explode all trees 
#16 arbitration* or arbitrat* or discordan* or discrepan* or disparity* or negotiat* 
or disagree* or conflict* or differen* or inconsisten* or variation* or consensus* or 
uncertain* 
#17 #15 or #16 




Appendix K. Cochrane Arbitration and Double Reading Search 
Last Saved: 19/01/2016 16:24:52.576 
Description: 
ID Search 
#1 MeSH descriptor: [Breast Neoplasms] explode all trees 
#2 breast adj3 (neoplasm* or carcinoma* or tumour* or tumor* or cancer*) 
#3 #1 or #2 
#4 MeSH descriptor: [Mass Screening] explode all trees 
#5 breast adj3 (scan* or screen* or radiograph* or imaging or visualise or visualize 
or exam* or test* or mammogra* or routine* or check* or diagnos* or detect*) 
#6 mammogra* adj3 (scan* or screen* or visualise or visualize or exam* or test* or 
breast*) 
#7 MeSH descriptor: [Mammography] explode all trees 
#8 #4 or #5 or #6 or #7 
#9 "Early detection of cancer*" 
#10 "National Health Service Breast Screening Program" or "NHSBSP" 
#11 "UK breast screen* program*" 
#12 "NHS breast screen* program*" 
#13 #9 or #10 or #11 or #12 
#14 #3 and #8 and #13 
#15 MeSH descriptor: [Negotiating] explode all trees 
#16 arbitration* or arbitrat* or discordan* or discrepan* or disparity* or negotiat* 
or disagree* or conflict* or differen* or inconsisten* or variation* or consensus* or 
uncertain* 
#17 #15 or #16 
#18 MeSH descriptor: [Image Interpretation, Computer-Assisted] explode all trees 
#19 "double-blind method*" or "double read*" or "double report*" or 
"reproducibility 
of result*" or "sensitivity and specificity" or volume* or fatigue* or optimal 
#20 #18 or #19 
















Web of Science 
Search History - " arbitration 05/16" 
 
#5 
#3 AND #2 AND #1 
Refined by: LANGUAGES: (ENGLISH)  
DocType=All document types; Language=All languages; 
#4 
#3 AND #2 AND #1  
DocType=All document types; Language=All languages; 
#3 
TOPIC: (Negotiation or Negotiations or Mediation or Mediating or Arbitrating or Arbitration or 
Conflict Resolution or Conflict Resolutions or Resolution, Conflict)  
DocType=All document types; Language=All languages; 
#2 
TOPIC: (Mammographies or mammogram or mammography)  
DocType=All document types; Language=All languages; 
#1 
TOPIC: (breast neoplasm or breast carcinoma or breast tumour or breast cancer)  




Appendix N. CASP Diagnostic Checklist 
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